University of Denver

Digital Commons @ DU
Electronic Theses and Dissertations

Graduate Studies

1-1-2018

The Investigation of Lactoferrin Nitration: Quantification, Function,
and Inhibition
Amani Yahya Alhalwani
University of Denver

Follow this and additional works at: https://digitalcommons.du.edu/etd
Part of the Biochemistry Commons, and the Environmental Chemistry Commons

Recommended Citation
Alhalwani, Amani Yahya, "The Investigation of Lactoferrin Nitration: Quantification, Function, and
Inhibition" (2018). Electronic Theses and Dissertations. 1452.
https://digitalcommons.du.edu/etd/1452

This Dissertation is brought to you for free and open access by the Graduate Studies at Digital Commons @ DU. It
has been accepted for inclusion in Electronic Theses and Dissertations by an authorized administrator of Digital
Commons @ DU. For more information, please contact jennifer.cox@du.edu,dig-commons@du.edu.

THE INVESTIGATION OF LACTOFERRIN NITRATION: QUANTIFICATION,
FUNCTION, AND INHIBITION
__________

A Dissertation
Presented to
the Faculty of Natural Sciences and Mathematics
University of Denver

__________

In Partial Fulfillment
of the Requirements for the Degree
Doctor of Philosophy
__________

by
Amani Yahya Alhalwani
June 2018
Advisor: John Alexander Huffman, PhD

©Copyright by Amani Yahya Alhalwani 2018
All Rights Reserved

Author: Amani Yahya Alhalwani
Title: THE INVESTIGATION OF LACTOFERRIN NITRATION: QUANTIFICATION,
FUNCTION, AND INHIBITION
Advisor: John Alexander Huffman, PhD
Degree Date: June 2018

Abstract

Lactoferrin (LF) is an iron-binding glycoprotein of molecular mass ca. 80 kDa
that is predominantly found in mammalian body fluids. Lactoferrin is a multifunctional
protein that has a wide range of properties such as antibacterial, antiviral, antiinflammatory, and anti-allergic functions. Tyrosine residues in the protein play a part in
many lactoferrin functions. Protein tyrosine nitration modification represents an oxidative
and nitrosative stress process which can be caused by the exposure of proteins to
oxidants from air pollution or disease. Understanding the way nitrated lactoferrin
interacts with the biochemical environment of the body is thus important to the broader
goal of understanding and preventing lactoferrin-related diseases, including certain ocular
diseases. The main goal of this set of linked studies was to investigate the process by
which LF may be nitrated, to observe changes in its protein structure and function, and to
investigate a possible route to block the nitration process.
In the first project discussed here, nitrated lactoferrin was synthesized using two
different nitration agents: sodium peroxynitrite and tetranitromethane. After nitration,
spectroscopic analysis showed formation of nitrotyrosine with an increase in absorbance
intensity at 350 nm, as well as attenuation in fluorescence intensity at an excitation
wavelength of 280 nm. A sandwich ELISA protocol was developed to quantify the
amount of nitrotyrosine in nitrated lactoferrin samples. The results show that the increase
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in the amount of nitrotyrosine depends on the molar ratio of nitrating agents added to the
reaction. This study represents the first time that nitrotyrosine in lactoferrin had been
selectively detected. In the second project, a broth microplate antibacterial susceptibility
assay was applied to determine changes in the antibacterial function of lactoferrin
brought about after nitration. The results reveal a reduction in the naturally present
antibacterial activity of LF, which scales linearly with the increase in nitration molar
ratios. In the third project, ergothioneine was used to inhibit the nitration reaction using
several protein models, as well as to examine it as a potential therapeutic target for
nitrosative stress-related diseases. The results illustrated that ergothioneine diminished
the nitration production and protected the protein antibacterial activity. Collectively,
these findings suggest that the nitration of tyrosine residues within lactoferrin can be
important with respect to several physiological processes. Thus, further understanding the
interaction between nitrated LF and the biochemical environment may aid in future
research toward clinical diagnoses and in the development of therapies for diseases
involving nitration of lactoferrin.
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Chapter one: Introduction
1.1 Overview of lactoferrin
1.1.1 Background of lactoferrin
Lactoferrin (LF) is a protein found widely within the physiological system of
mammals. LF was discovered in 1939 by M. Sørensen and S. P. L. Sørensen in bovine
milk. An alternative name for lactoferrin is lactotransferrin due to a similar structural
homology to transferrin, (Masson, et al. 1971). This name was proposed by Blanc and
Isliker in 1961 (Blanc, et al. 1961). It exists in mammals and is found mainly in granules
of neutrophils and is present in secreted fluid such as tears, milk, and saliva (Masson, et
al. 1966). It is produced by acinar epithelial cells and neutrophils (Baggiolini, et al. 1970;
Spitznagel, et al. 1974).
1.1.2 Structure of lactoferrin
LF is a monomeric glycoprotein with molecular weight 80 kDa and containing 703
amino acids residues (Metz‐Boutigue, et al. 1984) . It consists of two globular lobes (C
and N) which are connected via an α-helix (Metz‐Boutigue, et al. 1984; Adlerova, et al.
2008). The net charge of LF is positive (González-Chávez, et al. 2009). LF is able to bind
and transfer non-heme iron (Fe3+) ions (Metz‐Boutigue, et al. 1984; Baker, et al. 1990) .
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1.1.3 Iron binding sites on lactoferrin structure
Each globular lobe has identical composition and function. The lobes contain two
domains: the N-lobe has N1 and N2 domains and the C-lobe has C1 and C2 domains, e.g.
Figure 1. a in (García-Montoya, et al. 2012). Each globular lobe in LF has one active
binding site to bind to Fe3+, which makes each mole of LF bind to two moles of Fe3+
(Adlerova, et al. 2008). The binding site in each lobe comprises of four amino acids
which are: two tyrosines (Tyr), one aspartic acid (Asp), and one histidine (His).
Particularly, Asp-61, Tyr-93, Tyr-193, and His 254 in the N-lobe and Asp-396, Tyr-436,
Tyr-529, and His 598 in the C-lobe (Anderson, et al. 1989b). These amino acids provide
negative charges to balance the Fe3+ charge via the two phenolate oxygens from Tyr, one
carboxylate oxygen from Asp, and one imidazole nitrogen from His, and the arginine
(Arg) side chain with the N-terminus helix provides positive charges to balance CO32charge, shown in Figure.1 b in (García-Montoya, et al. 2012).
The N-lobe of the protein has an open binding cleft which closes when it binds to
metal. The C-lobe cleft remains closed with or without binding to metal. Also, LF
changes the form of the lobes due to binding. LF has a closed form when it binds to Fe3+;
LF has an open form when it is free to bind, shown in Figure 1. A and B in (Latorre, et al.
2010). LF has three iron binding forms: not bound to iron (apolactoferrin), and bound to
two irons (hololactoferrin) (Latorre, et al. 2010).
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1.2 Lactoferrin function
1.2.1 Lactoferrin function dependent on iron
LF receptors bind to iron in LPS (lipopolysaccharide) within the bacterial wall
and inhibits the growth (Krewulak, et al. 2008). Also, LF binds to glycosaminoglycans of
eukaryotic cell and prevent viruses from binding, see Figure 3 in (González-Chávez, et al.
2009).
Some biological functions are determined by LF, such as antioxidant properties
provided to the cell via the production of hydroxyl radicals within leukocytes
(Kanyshkova, et al. 2001). LF shows some of these biological functions because of the
iron-binding capacity of the protein. The antioxidant function of LF, for example,
relates iron-binding properties to hydroxyl radicals production in leukocytes, which the
protein accomplishes without releasing O2 and H2O2 (Kanyshkova, et al. 2001).
1.2.2 Lactoferrin function independent of iron
LF is able to attach to the surfaces of many types of cells via surface properties
such as monocytes (Birgens, et al. 1983). The main part of LF molecule that binds to the
cell surface is the N-terminal lobe. For example, LF competes with binding activity of
lipopolysaccharides (LPS) in the bacteria wall to bind to immature dendritic cells from
(CD14) receptors deficient mice and prevent inflammation (Baveye, et al. 1999).
1.2.3 The surface properties of lactoferrin
The LF protein has an isoelectric point (pI~ 9) which makes it a cationic surface.
Additionally, LF has properties to bind to the macromolecule independent from the iron
binding site (Baker, et al. 2009). Several of LF antimicrobial functions are associated to
the surface cationic charge, which is mainly in the N-lobe (Valenti, et al. 2005).
3

1.3 Lactoferrin functions.
LF has two known mechanisms for antibacterial functions. The LF antibacterial
mechanism that remains unknown is the interaction which prevents the bacteria from
attaching to the host cell receptors (González-Chávez, et al. 2009). The bactericidal
function shows the direct interaction of charge on the LF molecule, e.g. Figure 5 in
(Baker, et al. 2005) to the bacteria surface (Baker, et al. 2005). The bacteriostatic
function is related mainly to iron-binding properties which inhibits bacterial growth via
binding to the iron in the environment which is essential for the growth (Jenssen, et al.
2009). LF shows bacteriostatic action against E. coli, B. subtilis, B. stearothermophilus,
S. albus, S. aureus, and P. aeruginosa (Oram, et al. 1968; Masson, et al. 1966).
1.3.1 Anti-inflammatory properties
LF is called an acute-phase protein because it increases in concentration during
most of the inflammation reaction (Kanyshkova, et al. 2001). LF plays a crucial role in
inflammation by inhibiting the inflammation receptors (Conneely 2001). By binding to
specific receptors of the target cell surface, LF protects them from the damage by
oxidative radicals such as monocytes, macrophages, and hepatocytes (Brock 1995). Also,
it inhibits the production of tumor necrosis facor-α (TNF) and interleukin-1 (IL-1) in the
inflammatory process (Crouch, et al. 1992).
1.3.2 Antioxidant properties
LF in tears protects the corneal epithelial cells from UV damage through
inhibition of hydroxyl radical formation (Shimmura, et al. 1996). Furthermore, LF has an
antioxidant affect through the iron-binding site to prevent the production of the hydroxyl
radical (Wakamatsu, et al. 2008).
4

1.3.3 Antibacterial mechanisms of lactoferrin
a. Bactericidal mechanism
The cationic charge in LF at the N-terminal binds to the bacteria anion surface
lipopolysaccharides (LPS) and causes membrane damage (Roşeanu, et al. 2010). This
cationic nature is concentrated on the N-terminus at residues 1-7, the first helix at
residues 13-30, and the inter-lobe region, see Figure 2.A and B in (González-Chávez, et
al. 2009).
b. Bacteriostatic mechanism
The LF iron-binding site binds to the membrane of gram negative bacteria to
destabilize the membrane organization. The bacteria A. actinomycetemcomitans requires
magnesium cations to organize the membrane by stabilizing LPS and protect the bacterial
outer membrane which plays a role in the metabolic function (Kalmar, et al. 1988).
1.4 Protein nitration
1.4.1 Tyrosine nitration reaction
The protein Tyr nitration is the result of covalent reaction by the addition of nitro
group into the ortho position in aromatic ring (Riordan, et al. 1966). The specific Tyr
nitrating reagent is tetranitromethane (TNM) which produces mainly 3-nitrotyrosine
(NTyr) (Sokolovsky, et al. 1966). Also, the peroxynitrite (ONOO-) reagent used nitrate Tyr
and other amino acids, and it is suitable for in vivo study (Franze, et al. 2005; Shuker, et
al. 1993).
1.4.2 Nitration protein and biochemical properties
In vivo protein nitration is caused by reactive nitrogen species (RNS) including
peroxynitrite (ONOO-) and nitrogen dioxide (NO2) to produce 3-nitrotyrosine (NTyr)
5

(Aulak, et al. 2004). The NTyr is used as a marker to the protein function alteration in many
physiological and pathological systems (Turko, et al. 2002; Good, et al. 1998; Kim, et al.
2002; Franze, et al. 2003). After nitration, the pKa value of protein changes from pKa 10
to 7 due to the addition of NO2 in the protein structure, shown in Figure 1 in (Radi 2013).
The reduction on pKa affects protein function (Begara-Morales, et al. 2013). Nitration
makes the protein hydrophobic and adds steric hindrance to the protein structure (Savvides,
et al. 2002). The nitration process changes protein conformation. For example, α-synuclein
protein showed changes in folding conformation in vitro (Uversky, et al. 2005).
Additionally, nitration has been shown to form the protein oligomerization structure
(Kampf, et al. 2015). These changes in the chemical properties can play an important role
in protein activity dysfunction.
1.4.3 Protein nitration health implications
The protein nitration has been reported with direct correlation to diseases such as
cardiovascular disease (Turko, et al. 2002), neurodegenerative disease (Good, et al. 1998),
and ocular disease (Kim, et al. 2002); and indirect exposure to substances such as birch
pollen which linked to the increase in allergenic diseases (Franze, et al. 2003). These
implications highlight the need for further investigation in the biochemical properties of
protein nitration to explore the function changes or addition in the protein.
1.5 LF nitration modification
1.5.1 The effect of chemical modifications to LF function
Protein chemical modification has previously been used to study LF structure and
functional activities (Hutchens, et al. 2012). The protein was modified with several site6

specific amino acids such as cysteine, methionine, tryptophan, and tyrosine (Lundblad
2018). LF activities changed due to the type of chemical modifications. For example,
amidation chemical modification in LF improved antimicrobial function but acylation
eliminated antimicrobial and antiviral properties (Pan, et al. 2007). The nitration chemical
modification in LF changes iron-binding properties (Teuwissen, et al. 1973). The focus of
this work was on protein nitration specific to tyrosine (Tyr) residues. Protein nitration is
an important tyrosine modification because it is linked to oxidative stress, inflammation,
aging, and many other diseases (Ogino, et al. 2007; Andreadis, et al. 2003; Tsang, et
al. 2009; Elahi, et al. 2009; Yeo, et al. 2008). A study showed a reduction in iron
binding of LF after mutation via converted tyrosine residues in both binding sites
(Tyr-93, Tyr-193, Tyr-436, and Tyr-529) to alanine residues (Ward, et al. 1996).
1.6 Analytical techniques to characterize protein nitration
Modification of Tyr to NTyr can play an important role in the physiological
system, and the ability to detect and quantify the modified residues can be
impactful for a number of medically-relevant research endeavors. For example,
Ischiropoulos reviewed several methods to determine the NTyr concentration in
diseased samples of human and animal tissue (Ischiropoulos 1998). NTyr has been
quantified using Western blot (WB) (Hinson, et al. 2000), enzyme-linked
immunosorbent assay (ELISA) (ter Steege, et al. 1998), high-performance liquid
chromatography (HPLC) (Crow, et al. 1995), and gas chromatography paired with
mass spectrometry (GC-MS) (Dalle‐D onne, et al. 2006) techniques. Tandem mass
spectrometric (MS/MS) analysis is the most sensitive for detecting low
concentrations of NTyr and was used to investigate the relationship of nitrated
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proteins to many diseases, but requires very high up-front cost (ca. $300k to
$1,000k) and high maintenance costs (Yeo, et al. 2008; Reinmuth-Selzle, et al.
2014). To overcome some of the limitations presented by MS analysis, many
studies now substantiate that ELISA can be applied to selectively detect
nitrotyrosine within a sample (Baker, et al. 2000).
1.7 Nitration inhibitor
Through aging and disease, the concentration of ONOO- can be increased
dramatically and can both alter and impair biological function via nitration reaction. It is
important to maintain the protein structure by preventing nitration reaction using nitration
inhibitors.
There are several nitration inhibitors such as glutathione (GSH) which acts by
reacting the thiol group with peroxynitrite to prevent nitration (Sies, et al. 1997).
Hydroxycinnamates acts to protect Tyr from nitration by preventing the electron transfer
reaction (Pannala, et al. 1998), polyhydroxyphenols by scavenging hydroxyl radical (OH)
(Chung, et al. 1998), selenocystine, selenomethionine and ebselen by a catalytic cycle to
reduce peroxynitrite to nitrite (NO2-) (Sies, et al. 1996), and ergothioneine (Ergo) by by
scavenging ONOO- (Aruoma, et al. 1997). The study showed that Ergo is more effective
as antioxidant activity towards peroxynitrite radical than other antioxidants for example;
80% higher than GSH or Trolox C and 25% higher than uric acids by protecting Tyr
residues from peroxynitrite (Aruoma, et al. 1997; Franzoni, et al. 2006a).
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1.8 Lactoferrin and health
1.8.1 The effect of peroxynitrite in eye
The presence of ONOO- in the eye is generated from over-production of .NO and
O2.- in tissue and that was caused by physiological and pathological conditions (Allen, et
al. 1998). For example, an in vitro study showed the effect of inflammation, which
increased the production of nitric oxide synthase (NOS) in tear fluid and on ocular
surface tissues, causing damage to the ocular surface. In that study the concentration of
NOS in tears was 1.5-5 µM and 5-110 µM in aqueous humour (Park, et al. 2001). The
oxidative stress markers nitrotyrosine, as a marker for nitric oxide, and malondialdehyde,
as a marker for lipid peroxidation, were detected in human corneal disease and showed a
significant relation of oxidative damage to corneal disease. In Figure 1 at (Buddi, et al.
2002) shows the possible pathways of oxidative stress markers which is produced by
endothelial nitric oxide (eNOS) or inducible nitric oxide( iNOS)for protein nitration and
reactive oxygen species for lipid peroxidation (Buddi, et al. 2002).
1.8.2 The effect of protein nitration in ocular surfaces
Ocular surfaces have been studied after being directly exposed to oxidative stress
via environmental conditions and air pollution (Wakamatsu, et al. 2008). An association
exists between traffic-borne air pollution and ocular diseases (Novaes, et al. 2007;
Torricelli, et al. 2014). Increased NO2 concentration from vehicle pollution is
linked to an increase of the inflammatory response of ocular surfaces (Novaes, et
al. 2010b). Also, oxidative stress affects the ocular health endogenously through
diseases caused by inflammation (Bosch-Morell, et al. 2002; Chiou 2001). Protein
tyrosine nitration occurs by tetranitromethane or peroxynitrite (Nakaki, et al. 1999). This
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nitration happens by the addition of a nitro group in the phenolic ring of the tyrosine
molecule. Protein tyrosine nitration produced NTyr, 6-nitrotryptophan, and 3,3’dityrosine (Thiagarajan, et al. 2004). The NTyr is used a biomarker for several diseases
such as asthma, hypertension, sickle cell disease and dry eye disease (Greenacre, et al.
2001). There is only one study that has been done for lactoferrin nitration. This study, by
Teuwissen et al. showed changes in LF iron-binding properties during the nitration
process (Teuwissen, et al. 1973).
1.8.3 Lactoferrin and disease
Lactoferrin associated with many diseases such as diabetes (Moreno-Navarrete, et
al. 2009), Crohn's (Sipponen, et al. 2008), neurodegenerative diseases (Grau Armin, et
al. 2001), and dry eye diseases (Ohashi, et al. 2003). Lactoferrin is important and
widespread within mammalian bodily fluid, and our interest is to investigate it in relation
to the ocular surface. The motivation of nitrated lactoferrin in our research relates to
ocular disease due to the lack of study in this area. It is important to us to understand the
role of lactoferrin in ocular surface and the related ocular diseases.
1.8.4 Lactoferrin role in tears
The tear film is a thin layer of fluid that covers and protects the ocular surface.
Tears work as a carrier and excretory system for nutrients and metabolic products from
corneal tissue (Tiffany 2003; Brock 1995). The ocular surfaces is covered in three layers:
outer lipids (hydrophobic barrier), middle aqueous (physiological barrier such as
electrolytes and proteins), and inner mucin (hydrophilic barrier) (Tiffany 2003). The
thicknesses of the tear film ranges depend to each layer as the follows: 0.1–0.2 µm for
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lipid, 7 to 8 µm for aqueous, and 30 µm for mucin layers (Johnson, et al. 2004; Walcott
1998).
The aqueous layer is an important film layer to the ocular health because it
contains many components that protect the ocular surface. It contains electrolytes,
vitamins, hormones, enzymes, immunoglobulins, and protein (Johnson, et al. 2004).
Proteins in the tear are important to maintain ocular surface health and the changes in this
protein composition will affect ocular health (Zhou, et al. 2006). Proteins in the tear are
secreted mainly by the lacrimal gland (Prabha 2014). The tear has a high protein
concentration of 8 µg/µL proteins and more than 60 proteins present, such as lacitin,
proline rich proteins, lipocalin, lipophilin, lysozyme, and LF (de Souza, et al. 2006;
Johnson, et al. 2004). LF has been shown to represent 25% of the tear protein
concentration, making it a biomarker tear proteins for ocular diseases (Kijlstra, et al.
1983).
1.8.5 LF role in cornea
It has been determined that LF is present in human and murine eye tissues such as
retina, iris, and cornea (Rageh, et al. 2016). LF works as a host defense protein due to
multifunctional properties, such as its antibacterial and anti-inflammatory abilities, which
plays an important role to protect ocular surface (Flanagan, et al. 2009).
1.8.6 The relation between ocular surface health and nitration
There are two possible ways for the nitration reaction to the human body:
endogenous and exogenous. The endogenous pathway for nitration reaction via
peroxynitrite that related to overproduction of nitric oxide (NO) and superoxide (-O2).
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This increasing showed a relation to eye diseases such as utveitis and myopia (Chiou
2001). Also, review paper showed NO affect many part of the eye and caused diseases
(Becquet, et al. 1997).
One exogenous pathway by which nitration reaction can occur is via reaction with
reactive pollutant gases formed in urban atmospheres. The ocular surface can be directly
exposed to gas-phase pollutants, which can then lead to certain medical conditions
including various diseases. Previous studies have shown that long-term or acute exposure
air pollution from traffic or industrial sources can cause ocular surface dysfunction and
changes in tear film stability (Novaes, et al. 2010a; Torricelli, et al. 2013). Torricelli et al.
(2011) presented a review discussing that the influence of long term exposure to outdoor
air pollution such as nitrogen dioxide (NO2), ozone (O3), carbon monoxide (CO), and
particulate matter (PM2.5) can lead to ocular surface alterations (Torricelli, et al. 2011).
One study showed that a healthy worker who is exposed to traffic air pollution that
contains a high level of NO2 (>100 µg/m3 equivalent to 48 ppb) and PM2.5 (40 µg/m3)
showed ocular surface irregularity and reduction in tear film osmolality (Torricelli, et al.
2014). All these studies tested the changes of the ocular surface using qualitative methods
such as tear breakup time, the Schirmer test, and vital staining test. The investigation of
the changes of the ocular surface components needs more consideration to understand the
reason behind the observed irregularities.
1.9 Motivation
Protein nitration is a type of chemical modification that can be related to allergies,
respiratory distress, and ocular disease in humans. Environmental exposure to air
pollutants in urban areas can not only cause physical damage to non-living surfaces,
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plants, and animals, but can also initiate damage to the ocular surface because it is in
direct contact with reactive atmospheric species such as nitrogen oxide and ozone. The
effects of this interaction are not known but could reasonably include changes in
lactoferrin, an ocular protein whose reduced concentration correlates with many ocular
diseases. The air pollution contains a mixture of chemical components that effect human
health via protein modifications such as nitration and oxidation reactions. These
modifications changed the natural characteristics of human tissue and caused diseases.
There are many studies of air pollution and human diseases but few focuses on ocular
surface disease. In order to promote this investigation, it is important to understand the
connection between the ocular surface marker and the effects of modifications caused by
air pollution. This research may help in the investigation and treatment of lactoferrinrelated diseases such as dry eye diseases.
1.10 Hypotheses
Several linked hypotheses were investigated.
- The nitration modification can attenuate antibacterial activity of lactoferrin.
Ergothioneine, an inhibitor of nitration, may be useful as a therapeutic treatment against
NLF-related disease.
- Lactoferrin is an important protein in tear film function, and nitration of LF may
actively It may be possible to develop a quantitative technique, such as sandwich ELISA,
that is both sensitive and selective enough to quantify nitrated lactoferrin.
- A potential nitration inhibitor, ergothioneine, might also be effective in treatments of
dry eye disease.
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1.11 Objectives
To evaluate this modification, this study was designed to first investigate nitration
reactions in the lab using two reactions as proxies of endogenous and exogenous models.
Reaction products were identified and characterized using spectroscopic analysis. Next, a
binding assay was developed in lab to quantify the nitration product. This assay is a novel
and unique detection method which has eventual potential application in the clinical
laboratory. Next, LF protein function was tested for biological changes using
antibacterial and circular dichroism assays. These biochemical functions were used to
evaluate the protein changes after nitration. Finally, an inhibitor molecule was applied to
the nitration reaction to investigate the reduction of the nitration process. This
investigation was used to work toward a possible anti-inflammatory treatment to protect
the protein from the nitration affect.
Our research focused on the nitration role in lactoferrin and how that affects the
bioactivities which can be useful in the clinical investigation for future research of ocular
health in urban areas.
1.12 Research Aims
This dissertation describes three interrelated projects: Chapter 2 discusses the
development of a novel sandwich ELISA to quantify nitrotyrosine in nitrated lactoferrin
samples. Chapter 3 discusses changes in the antibacterial activity of nitrated lactoferrin.
Chapter 4 discusses the effect of Ergo in protecting lactoferrin from the nitration process.
The outcome of these studies hopes to provide value toward understanding the effects of
protein nitration and its connection to maintaining health of ocular and other
physiological systems.
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Chapter two: Development of a sandwich ELISA with potential for selective
quantification of human lactoferrin protein nitrated through disease or
environmental exposure
Peer-reviewed and published in the following form, with only minor textual modification:
Anal Bioanal Chem. 2018 Feb;410(4):1389-1396. doi: 10.1007/s00216-017-0779-7.
Electronic publication date: December 6, 2017.
2.1 Abstract
Lactoferrin (LF) is an important multifunctional protein that comprises a large
fraction of the protein mass in certain human fluids and tissues, and its concentration is
often used to assess health and disease. LF can be nitrated by multiple routes, leading to
changes in protein structure, and nitrated proteins can negatively impact physiological
health via nitrosative stress. Despite an awareness of the detrimental effects of nitrated
proteins and the importance of LF within the body, cost-effective methods for detecting
and quantifying nitrated lactoferrin (NLF) are lacking. We developed a procedure to
selectively quantify NLF using sandwich enzyme-linked immunosorbent assay (ELISA),
utilizing a polyclonal anti-LF capture antibody paired with a monoclonal antinitrotyrosine detector antibody. The assay was applied to quantify NLF in samples of
pure LF nitrated via two separate reactions at molar ratios of excess nitrating agent to the
total number of tyrosine residues between 10/1 and 100/1. Tetranitromethane (TNM) was
used as a laboratory surrogate for an environmental pathway selective for production of
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3-nitrotyrosine, and sodium peroxynitrite (ONOO-) was used as a surrogate for an
endogenous nitration pathway. UV-vis spectroscopy (increased absorbance at 350 nm)
and fluorescence spectroscopy (emission decreased by >96%) for each reaction indicates
the production of NLF. A lower limit of NLF detection using the ELISA method
introduced here was calculated to be 0.065 µg mL-1, which will enable the detection of
human-physiologically relevant concentrations of NLF. Our approach provides a
relatively inexpensive and practical way to assess NLF in a variety of systems.
2.2 Introduction
Lactoferrin (LF) is an iron-binding protein that is present in many tissues
and fluids of the human body and is critical to diverse physiological functions
(Kanyshkova, et al. 2001). LF exists in various exocrine fluids such as tears, milk,
and saliva (Vorland 1999; Kijlstra, et al. 1983) and possesses significant
antifungal, antiviral, and antibacterial functions within the body (Jenssen, et al.
2009). Lactoferrin has a molecular weight of ca. 80 kDa and contains 703 amino
acids, including 20 tyrosine residues and two globular lobes linked by an α-helix
(Lönnerdal, et al. 1995). Each lobe contains two tyrosine residues at the center of
its structure that participate with other amino acids as one iron binding site
(Vorland 1999). The concentration of LF in human tissues has not been wellstudied, but is critical for physiological function (González-Chávez, et al. 2009).
Chemical modification of proteins like LF can also play important roles in
controlling protein function. Free radicals such as reactive oxygen species (ROS)
and reactive nitrogen species (RNS) are broadly important within the human body
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and as exogenous agents because they can lead to modifications that can affect
protein function and harm the living system (Valko, et al. 2007). Specifically, the
presence of nitrotyrosine-modified proteins is associated with many
neurodegenerative, cardiovascular, respiratory, and ocular surface diseases (Yeo,
et al. 2008). One mechanism by which tyrosine nitration may affect physiology is
through protein denaturation leading to an irreversible loss of function (Gow, et al.
1996). Damage to tissue can also induce an increase in NO synthesis, releasing
more peroxynitrite and leading to further increases in protein nitration (Pfeiffer, et
al. 2001). Thus, 3-nitrotyrosine (NTyr) can be used as a biomarker for nitrosative
stress diseases in body fluids such as blood, urine, and tears (Dalle‐D onne, et al.
2005). Many ROS and RNS exist within the human body and contribute to the
pathology of a variety of medical conditions. Peroxynitrite, in particular, has been
shown to induce nitration of tyrosine (Tyr) residues as well as those of several
other amino acids (Beckman 1996). One important pathway by which ONOOinduces tyrosine nitration involves an electron oxidation reaction of the phenolic
ring, which forms an intermediate radical at the 3-position of the ring, followed by
combination with NO2 to generate NTyr, as summarized in Figure 2. 1 (Radi
2013).
Significant effort has gone into the investigation of ROS in the atmosphere
and it is effects on human health. By comparison, relatively little study has been
invested in what parallel role RNS may play in the same environmental systems
(Wiseman, et al. 1996). One source of exogenous RNS is free radicals and reactive
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gases in the air that are emitted, directly or indirectly, by combustion sources and
are higher in polluted, urban areas (Reinmuth-Selzle, et al. 2017). Contact between
adjuvants such as pollutant gases and proteins on the surfaces or fluids of the skin,
eyes, mucous membranes, and lungs can provide an important pathway of
chemical reactivity (Lakey, et al. 2016), and exposure to nitrogen oxide gases
influences many cardiovascular, respiratory, and ocular surface diseases (Patel, et
al. 1999). Investigating the amount of nitrated proteins in urban road dust indicates
that proteins on the surface of pollen and other biological particles can be nitrated
in urban air and thus could influence human health (Franze, et al. 2005).
In the atmosphere, tyrosine nitration is thought to proceed through a
mechanism by which O3 and NO2 gases selectively produce a 3-NTyr product
(Franze, et al. 2003; Reinmuth-Selzle, et al. 2014; Kampf, et al. 2015), whereas
reaction with ONOO- can modify a wider set of amino acid residues, as discussed.
Tetranitromethane (TNM) is frequently used in the laboratory as a surrogate for
the heterogeneous O3 and NO2 mechanism, because it also selectively produces the
3-NTyr product (Franze, et al. 2005; Shuker, et al. 1993). Sokolovsky et al.
illustrated the TNM mechanism that inserts a nitro group into the aromatic ring
specifically at the ortho position to produce 3-NTyr as in Figure 2. 2 (Sokolovsky,
et al. 1966). It is important to note that both Figure 1 and 2 lead to nitrated tyrosine
residues, but that these can be at different sites within the protein.
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Figure 2. 2 Production of NTyr from Tyr reacting with tetranitromethane.
A number of laboratory techniques have been utilized to detect and quantify
NTyr, especially for medically-relevant research endeavors (Crow, et al. 1995).
Among those, tandem mass spectrometric (MS/MS) analysis is the most sensitive
for detecting low concentrations of NTyr and has been used to investigate the
relationship of nitrated proteins to many diseases, but requires very high up-front
(ca. $300k to $1,000k) and maintenance costs (Yeo, et al. 2008; Reinmuth-Selzle,
et al. 2014). To overcome some of the limitations presented by MS analysis, many
studies now show that enzyme-linked immunosorbent assay (ELISA) can be
applied to selectively detect and quantify low concentrations of nitrotyrosine
within a sample (e. g.Baker, et al. 2009). ELISA has been used to quantify LF
concentration in milk, plasma, and tear fluid (Kijlstra, et al. 1983) as well as NTyr
in plasma and urine (Jamshad, et al. 1998). Only once has the detection of
lactoferrin nitration been reported directly, however. Teuwissen et al. used a
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combination of iron binding capacity and optical rotator dispersion to detect
changing tyrosine properties upon nitration of LF (Teuwissen, et al. 1973).
Despite the importance of LF and nitrated proteins within the human system
and as biomarkers for many diseases, very little has been reported on chemical
modifications of LF. This is due in part to the challenges to inexpensively and
selectively quantify nitrated lactoferrin (NLF). We summarize two independent
methodologies to nitrate LF via aqueous reaction, utilizing TNM as a surrogate for
exogenous atmospheric nitration and ONOO- as a model of endogenous
physiological nitration pathway. Spectrophotometry was utilized as a method to
show modifications to the protein. Further, we describe herein the development
and optimization of a novel sandwich ELISA technique to selectively quantify
NTyr in lactoferrin after nitration by each pathway. Using the reported ELISA
protocol, we anticipate the ability to selectively quantify NLF at physiologically
relevant concentrations, nitrated by either endogenous or exogenous pathways in
human tissue and fluid samples, thus providing researchers without access to
expensive instrumentation an accurate and effective way to measure NLF.
2.3 Experimental
2.3.1 Endogenous nitration of LF using sodium peroxynitrite
The peroxynitrite reaction was prepared following the method reported by
Selzle et al. (Selzle, et al. 2013), replacing Bet v 1 with LF and adjusting for
differences in the number of tyrosine residues between the two proteins. According
to this procedure, 200 µL aliquots of 5.0 mg mL-1 LF in aqueous solution was
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pipetted into 2.5 mL glass vials. PBS buffer, followed by NaONOO, was then
added, and reaction solutions were stirred on ice for 2 hours. NaONOO was added
in different amounts corresponding to peroxynitrite to tyrosine (ONOO-/Tyr) molar
ratios of 10/1, 20/1, 30/1, 40/1, 60/1, 80/1, and 100/1. PBS buffer was added to a
total volume of 1000 µL for each solution at NLF concentration of 1.0 mg mL-1.
Previous work showed that concentrations of LF higher than this produced lower
nitration reaction efficiency (Vincent, et al. 1970). Details regarding materials and
reagents are listed in the supplemental material.
2.3.2 Exogenous nitration of LF using tetranitromethane
The tetranitromethane nitration reaction was prepared following the method
reported by Teuwissen et al. (Teuwissen, et al. 1973). Similar to the above
procedure, 200 µL aliquots of 5.0 mg mL-1 LF in aqueous solution was combined
with Tris buffer, followed by 200 µL of ethanol and TNM, in 2.5 mL glass vials.,
TNM was added in amounts corresponding to tetranitromethane to tyrosine
(TNM/Tyr) molar ratios between 10/1 and 100/1. Mixtures were stirred at room
temperature (RT) for 4 hours. Tris buffer was added to a total volume of 1000 µL
at NLF concentration of 1.0 mg mL-1.
In all cases described below, NLF used as standard reference material for ELISA
protocols was produced using the 40/1 molar ratio of TNM/Tyr reaction described
here. Also in all cases, LF and NLF concentrations are reported as ±5%, which was
limited by the precision of LF mass amount in the originally purchased vial.
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2.3.3 Spectroscopic analysis
For all spectroscopic analyses, quartz cuvettes were used, and LF and NLF
samples were diluted in PBS buffer. Dilution calculations were performed by
taking the molecular mass of LF, irrespective of mass changes due to nitration.
UV-vis absorption spectroscopy was performed using a Cary BIO 100
spectrophotometer. Absorption spectra were acquired in 2 nm steps from 250 to
500 nm.
Fluorescence spectroscopy was conducted using a Varian Cary Eclipse
Fluorescence G9800A spectrophotometer equipped with a xenon lamp as
excitation source. The excitation wavelength was stepped every 2 nm, and
fluorescence emission spectra were acquired from 200 to 500 nm at 2 nm
resolution.
2.3.4 Direct ELISA for characterization of nitrotyrosine antibody
Direct ELISA was used to determine the optimal dilution factor of the detector
antibody that was later used in the sandwich ELISA procedure. Nitrated bovine serum
albumin (NBSA, 6/1 TNM/Tyr) was serially diluted into carbonate buffer producing five
concentrations of NBSA. Microwells were coated in triplicate with each NBSA solution,
and pure carbonate buffer was used as a blank. The plate was covered, sealed with sterile
tape, and incubated at 4°C for 17 hours overnight. After incubation, the wells were
washed in duplicate by adding 200 µL of PBST (PBS with 0.05% Tween). Each
subsequent incubation step also followed a similar process of sealing, continuous shaking
during the incubation period using a rocking platform (UltraRocker, BIO-RAD), and then
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duplicate washing with PBST. After washing, wells were blocked with 200 µL of
blocking buffer (5% BSA in PBS) and incubated at RT for 2 hours. After washing, mouse
monoclonal to nitrotyrosine biotinylated antibody (anti-NTyr) was diluted in blocking
buffer in four different dilution ratios between 1:100 and 1:1000). 50 µL of each dilution
was added in triplicate and incubated for 1 hour at RT, thus utilizing 12 wells (four
dilution ratios X triplicate measurements) for each NBSA concentration. Next, 50 µL of
streptavidin-HRP (diluted 1:10,000 in blocking buffer) was added before incubation at
RT for 1 hour. Each plate was developed by adding 100 µL of TMB substrate to each
well and incubating at RT until the color turned blue (ca. 10 min). The substrate reaction
was stopped after 10 minutes by adding 100 µL of 0.5 N aqueous sulfuric acid,
prompting the solution to turn yellow. The optical absorbance of each well was measured
using a microwell plate reader (Tecan Infinite, M1000 PRO). Following standard
procedures (Rajasekariah, et al. 2003), the absorbance of the substrate background at 620
nm (blue) was subtracted from the absorbance at 450 nm (yellow) to produce the
absorbance values reported on all plots.
2.3.5 Sandwich ELISA for quantification of NLF
For the sandwich ELISA procedure introduced here, goat polyclonal to
lactoferrin non-conjugated antibody (anti-LF) was used as the capture antibody,
and mouse monoclonal to nitrotyrosine biotinylated antibody (anti-NTyr) was used
as the detector antibody (clone number CC.22.8C7.3). Details regarding the choice
and dilution ratio of antibodies are outlined in the supplemental material (Section
A. 6). Microwells were coated with 50 µL of diluted capture antibody and
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incubated at 4°C overnight. The plate was then washed and blocked as described
above. NLF was serially diluted into blocking buffer producing NLF solutions at
eight concentrations. After a second washing step, 50 µL of each of the eight NLF
solutions was added in triplicate to the plate and incubated at RT for 1 hour.
Blocking buffer was used for blank measurements. 50 µL of the detector antibody,
diluted in blocking buffer to a ratio of 1:100, was then added, and the plate was
incubated with shaking at RT for 1 hour. Streptavidin-HRP and TMB were added
following the ELISA protocol, as described above.
2.3.6 Data analysis
Data points are shown here as mean ± sample standard deviation (s).
Statistical analysis was analyzed using Igor Pro 7 (Wavemetrics, Inc.; Oregon,
USA). The experiments were carried out in triplicate and the results were subjected
to t-tests to provide a measure of significance.
2.4 Results and Discussion
2.4.1 Detection of NLF using absorption spectroscopy
After nitration of LF via the two pathways (TNM and ONOO-), nitration
products were detected using UV-vis absorption spectroscopy. Figure 2. 3 shows
absorption spectra of LF and NLF nitrated separately by ONOO- (NLFONOO-) and
TNM (NLFTNM) reactions. Absorption measurements at 280 nm are commonly
used as a general tool for the detection of proteins that contain at least one of the
three aromatic amino acids Phe, Tyr, or Trp. The spectrum of LF (Figure 2. 3,
black trace) shows one band at 280 nm, which represents absorption by a
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combination of these aromatic amino acids. The absorption spectrum of NLFTNM
(Figure 2. 3, red trace) shows a peak at 350 nm, consistent with the peak location
of nitrated tyrosine (Riordan, et al. 1966). An additional product of the reaction is
nitroformate, which also absorbs at 350 nm (Sokolovsky, et al. 1970). As a result,
the reaction mixture was purified (see supplemental section A. 3), and the
absorption spectra were compared before and after purification to verify the
presence of NLF without interference. Both spectra show the peak at 350 nm,
qualitatively verifying the presence of the product. Quantitative comparison is
more complicated due to uncertainties in concentration introduced by dilution
during purification.
The absorption spectrum of NLFONOO- (Figure 2. 3, blue trace) shows a NLF
peak at 350 nm as well as a double-humped peak at 280 from unreacted Phe, Tyr,
and Trp in the protein. The NLFONOO- product was not purified before
spectroscopic analysis, because secondary reaction products and degradation byproducts of ONOO- do not overlap with the 350 nm peak (Jankowski, et al. 1999).
As a result, the quantity of NLFONOO- product is unambiguous here. In the case of
the ONOO- reaction, modification of the protein is not limited to tyrosine, and the
absorption spectrum of the nitrated product can be broadened by nitration of Phe,
Tyr, and Trp residues (ter Steege, et al. 1998). Further, the relative tyrosine
nitration yield from ONOO- is reduced compared to the TNM reaction, because the
ratio of ONOO- to the sum of all nitrate-able amino acids is lower than the ratio of
TNM to Tyr (Ischiropoulos, et al. 1992).
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Figure 2. 3 Absorption spectra of lactoferrin and nitration products from two
nitration reactions (1 mg mL-1 each). Each NLF product produced at 1/40 molar
ratio of Tyr to respective nitrating reagent. NLFTNM product shown in purified
form to remove interference from nitroformate by-product.
2.4.2 Detection of NLF using fluorescence spectroscopy
Fluorescence spectroscopy has also been frequently used to detect protein
modifications, due to changes that can take place in protein molecular
conformation (Kronman, et al. 1971). Tyr exhibits among the highest fluorescence
quantum yield of all amino acids, and it is the primary source of fluorescence in
proteins without Trp. When situated sufficiently close (ca. <5 nm) to Trp within a
protein structure, however, Tyr experiences efficient resonance energy transfer to
Trp and so is often not responsible for observed fluorescence (Lakowicz 2013;
Pöhlker, et al. 2012). LF exhibits relatively strong fluorescence emission because it
contains a large number of aromatic amino acids, including Phe (32), Tyr (20), and
Trp (10) (Bläckberg, et al. 1980). Fluorescence from nitrated proteins has
previously been shown to reduce total intensity from native proteins and can thus
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be used as a quantitative measure of nitration (Crow, et al. 1996; De Filippis, et al.
2006).
Figure 2. 4 shows fluorescence excitation emission matrices for native LF
as well as for NLFTNM and NLFONOO-. In the presence of nitrating agents, the
addition of a nitro group (NO2) onto Tyr decreases the pKa of the hydroxyl group
in the phenolic ring. As a result, the substitution of a large hydrophobic NO2 group
sterically hinders the tyrosine structure and can cause conformational changes to
the protein (Radi 2013). This reduces the absorbance intensity due to the
unmodified protein and also the intensity of the fluorescence emission.
LF shows strong emission centered at λEm 330 nm for two excitation bands
at λEx 224 and 280 nm due to a large number of Tyr and Trp residues, consistent
with previous studies (Meyer, et al. 2015). Both nitrated products show
dramatically decreased emission intensity (Figure 2. 4 d; NLFTNM, 98% decrease
and NLFONOO-, 96% decrease) due to the addition of NO2 groups to LF,
qualitatively matching observations for nitrotyrosine reported by Crow et al.
(Crow, et al. 1996). The emission intensity of NLFTNM is reduced by a greater
factor than NLFONOO-, again because ONOO- nitrates more broadly than TNM.
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Figure 2. 4 Fluorescence EEMs for native LF (a), NLFTNM (b), and NLFONOO(c). Diagonal lines indicate elastic scattering from excitation source. EEM color
scale indicates emission intensity, in logarithmically scaled arbitrary units (arb.).
Peak emission intensity at λEX280 nm for each panel summarized in panel (d).
2.4.3 Design of sandwich ELISA assay for quantification of NLF
The sandwich ELISA developed here was designed to detect NTyr bound to
LF protein in NLF samples. The assay first utilizes polyclonal anti-LF capture
antibodies to bind LF proteins. This antibody recognizes a specific sequence of 13
amino acids in the LF protein (see supplemental Section A. 4) (abcam 2017).
Second, monoclonal anti-NTyr detector antibodies are used to attach to specific
NTyr residues bound on captured NLF proteins. For the capture process,
polyclonal antibodies were used to enhance the probability of binding, given the
many sites at which nitration could affect LF binding, whereas monoclonal
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antibodies were used as detector antibodies to selectively enhance the assay’s
sensitivity (Fig. A. 2). The scheme is conceptually similar to the sandwich ELISA
protocol introduced by Franze et al., which detects NTyr in nitrated birch pollen
protein (Nitro-(3)-Bet v 1) and used rabbit polyclonal anti-Bet v 1 protein as
capture and mouse monoclonal anti-NTyr as detector antibodies (Franze, et al.
2003). The detector antibody chosen here has been used in many immunoassay
applications (Ferrante, et al. 1997) because it has low cross-reactivity (Chou, et al.
1996) and high sensitivity (Aggarwal, et al. 2011). See supplemental Section A. 6
and Figures A. 1-A. 2 for additional details about assay development.
2.4.4 Development of sandwich ELISA
In order to develop the modified sandwich ELISA for detection of NLF,
each of the two antibodies was tested separately using direct ELISA and combined
into a single sandwich ELISA. As a first step, direct ELISA was used to determine
the optimal buffer dilution ratio of NBSA antigen to the nitrotyrosine biotinylated
antibody (analogous to supplemental Fig. A. 3, without the initial capture antibody
step). Four dilutions ratios from 1:100 to 1:1000 were investigated. The 1:100
dilution exhibited the highest binding sensitivity, shown as the steepest slope in
Figure 2. 5.
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Figure 2. 5 Optimization of detector antibody using direct ELISA. The optical
absorbance shows ELISA well absorbance at four dilution factors (anti-NTyr into
blocking buffer). Data points are mean values ± s, n= 2. Traces are linear fits.
As a second step, the full sandwich ELISA was used to optimize the
dilution of capture antibody (anti-LF). The 1:1000 (v/v) dilution of capture
antibody was selected, because it exhibited binding sensitive similar to the 1:250
(v/v) dilution, but requires less antibody volume (Fig. A. 4). Using the higher
dilution thus achieves sensitive detection at lower cost.
A calibration curve of optical absorption versus NLF concentration was
developed as the final detection step of the sandwich ELISA (Figure 2. 6). A range
of molar ratios between 10/1 and 100/1 were investigated (Fig. A.5-A.6), and the
40/1 molar ratio of TNM/Tyr was chosen as the protein standard. Sandwich ELISA
results show a decrease in detected NLF concentration produced at nitration ratios
higher than 40/1. The reason for this could be due to a reduction in antibody
binding due to LF changes at capture antibody binding sites or as a result of
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denaturation of LF protein. Results published by Teuwissen et al. also show
NLFTNM properties peaking at a 40/1 molar ratio (Teuwissen, et al. 1973).
The limit of detection (LOD) for the newly developed assay was calculated
by two separate methods by measuring the mean + three times the sample standard
deviation of a set of three absorbance measurements following sandwich ELISA.
LODLF was calculated as 0.032 absorbance units (AU) by replacing native LF for
NLF as the antigen in the assay, and LODblank was calculated as 0.022 AU by
withholding any antigen from the assay. A minimum detectable NLF concentration
of 0.065 µg mL-1 was calculated as 3 sLF/m, where sLF is the standard deviation of
the blank measurement and m is the slope of NLF calibration curve. Using the
responses from the sandwich ELISA (Figure 2. 6), t-tests showed the NLF
measurement to be statistically different (p-value < 0.01) from the LF
measurement at all antigen concentrations measured (minimum 0.18 µg mL-1; see
supplemental Table A.1).
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Figure 2. 6 Sandwich ELISA calibration curve.
for NLF (40/1 TNM/Tyr) and LF in several concentrations (0.18, 0.37, 0.75, 1.5,
3.0, 6.0, 12.0, and 25.0 µg mL-1). Data points are mean values. Vertical
error bars
(black) shown as standard deviation s, n= 4. Linear fit for NLF, R2 = 0.993.
To confirm the results from the new ELISA protocol, Figure 2.5 shows that
the molecular absorbance of NLF (black traces) and responses from the sandwich
ELISA (red bars) each increase with increasing molar ratio of TNM or ONOO- to
Tyr. Supplemental Figure A.5 shows an extension of the ELISA response to higher
ratios of nitrating agent.
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Figure 2. 7 UV-vis absorbance at 350 nm (black traces; left axes) and ELISA optical
density at 450 nm (red bars; right axes) of NLF using two different nitration reagents;
ONOO- (a) and TNM (b). Error bars on ELISA data represent standard deviation of
measurements from individual wells (a) n = 6, (b) n = 3.
NLF samples produced using the TNM reaction were tested in both purified
and non-purified forms, following procedures outlined above. Absorbance values
and sandwich ELISA results show no statistical differences, and so all NLFTNM
data shown here (Figure 2. 6 and Figure 2. 7) are shown without any purification
(see supplemental material and Fig. A. 7). The ability of the assay to work
effectively without cleaning the product is important, because it shows that the
ELISA protocol developed here can be applied broadly to samples extracted from
tissues and fluids without need to perform additional cleaning steps that can
increase analysis costs and quantitative uncertainty. In contrast to this, the
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NLFONOO- samples can degrade over time if produced via the reactions outlined
above. NLFONOO- samples thus require purification before storage to limit
agglomeration and protein changes induced by the presence of excess ONOO(Estillore, et al. 2016).
2.5 Conclusions
NLF samples were synthesized using two different nitration reagents in
varying ratios of molar excess. ONOO- was used as an endogenous model and
TNM was used as an exogenous model. Both nitrated products were characterized
by UV-vis and fluorescence spectroscopy, showing dramatic changes upon
nitration. To quantify the concentration of NLF produced from each reaction, we
developed a novel sandwich ELISA for the selective detection of NTyr bound
within NLF antigens. We demonstrate a LODLF of 0.032 AU and a LODblank of
0.022 AU, translating to a lower limit of detectable NLF concentration of 0.065 µg
mL-1. An important feature of this sandwich ELISA protocol is that is does not
require sample purification, meaning that quantitative uncertainty introduced from
imprecise dilution through washing steps can be avoided. The NLF sandwich
ELISA introduced here is a novel method that was demonstrated to be applicable
to the quantification of nitrotyrosine in lactoferrin. LF is the most concentrated
protein in human tears, representing up to 25% of protein mass, or approximately
2.2 mg mL-1 (Kijlstra, et al. 1983). The concentration of ONOO- generated in
inflamed corneal tissue has been shown to be in the approximate range of 3-30 µM
(Ashki, et al. 2014). NLF has never been quantified in tissue or fluid samples, but
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if even 30 of every 106 LF molecules (30 ppm) were nitrated by ONOO-, NLF
concentrations would be above detection limits reported here. Thus, NLF is likely
to be detectable by this procedure at physiologically relevant concentrations. As a
result, this assay has important application to the investigation of NLF produced
through inflammatory pathways in human tear, milk, and ocular tissues samples,
and also through inflammation linked to traffic-borne air pollution.
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Chapter three: Nitration reduces antibacterial activity of lactoferrin by changing its
structural and functional properties
In preparation for submission for peer review.
3.1 Abstract
Protein nitration is an important protein modification that has been correlated with
both disease and urban air pollution. Here we examine the antibacterial properties of
lactoferrin (LF) protein, which plays an important role in the biological system as one of
the most concentrated proteins in several human fluids and tissues. Peroxynitrite (ONOO) was used to induce nitration on LF as a mimic of physiologically relevant biochemical
modification, producing nitrated lactoferrin (NLF). The reaction selectively generates
nitrotyrosine residues, which are commonly used as biomarker molecules for a number of
diseases. Our results show that nitration of LF at 10/1 and 40/1 molar ratios was sufficient
to inhibit all of the antibacterial activity exhibited by native LF. Secondary structural
changes in the LF protein were assessed using circular dichroism (CD) spectroscopy.
Spectral changes upon nitration in both unligated and iron-bound cases show a significant
reduction in alpha-helical properties, suggesting partial protein unfolding. Iron-binding
capacity of LF also showed reduction after nitration using two separate assays. This study
is the first to show inhibition of antibacterial properties of NLF, and the observations thus
represent a possible link to pathways of biochemical modification that take place during
diseases and due to environmental exposure. By understanding the critical role that
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nitration could play in the immune defense system of the human eye, liver, and other
organs, biochemical treatments may be explored that could reduce damage directly from
nitration pathways, and also due to secondary bacterial infections.
3.2 Introduction
(Strøm, et al. 2002; Kang, et al. 1996b)(Nuijens, et al. 1996)(Ward, et al. 2002)LF
is a member of the transferrin family of proteins that binds iron ions (Fe3+) and regulates
iron levels in the physiological system. Specifically, LF functions as an iron transporter
and serves important bacteriostatic and anti-viral roles (Farnaud, et al. 2003). The protein
structure consist of two iron binding sites, each of which can bind with an individual Fe3+
ion (Adlerova, et al. 2008). The iron binding site in each lobe consists of four amino acid
residues: two tyrosine, one aspartic acid, and one histidine. Thus, the protein provides
four ligands at each binding site: two phenolate oxygen atoms from Tyr, one carboxylate
oxygen from Asp, and one imidazole nitrogen from His (Baker, et al. 1990).
LF is widely used as an antibacterial agent against both gram-positive (e.g.
Streptococcus faecalis) and gram-negative bacteria (e.g. Escherichia coli), though gramnegative bacteria are more resistant than gram-positive bacteria due to the presence of
outer membranes (Rt D. Ellison, et al. 1988). LF serves antibacterial functions by two
separate mechanisms. As a bacteriostatic agent, LF serves to limit bacterial growth by
binding Fe3+, thereby reducing the concentration of available iron required for growth. As
a bactericidal agent, LF can bind to the surface of bacterial cells, releasing
lipopolysaccharide, which damages the bacterial membrane and can ultimately kill the
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cell (Rt D. Ellison, et al. 1988). It is important to note that due to the iron-binding
properties of LF, iron-bound LF shows no antibacterial activity (Dionysius, et al. 1993).
As a result of the interactions between the protein and either Fe3+ or the bacterial
surface, chemical modifications at certain amino acid residues of the LF structure are
likely to impact the protein’s physiological functions. For example, modification of LF
by replacing histidine with glutamic acid, cysteine, tyrosine, or methionine, was shown to
reduce the iron-binding function of the protein (Nicholson, et al. 1997). Nitration of
tyrosine resides bound within proteins has also been shown to be possible via several
mechanisms and has been linked to a variety of deleterious health effects (Radi 2013).
Peroxynitrite is one of the most effective endogenous protein nitrating agents, inducing
changes in protein structure and function, and has been implicated as a stressor related
e.g. to cardiovascular disease (Thiagarajan, et al. 2004; Saxena, et al. 2003). In particular,
3-nitrotyrosine has been used as a marker for inflammation and nitrosative stress
(Eleuteri, et al. 2009) and is also selectively produced by reaction with certain
environmental pollutants (Shiraiwa, et al. 2017; Franze, et al. 2005).
Despite the depth of literature that has focused on lactoferrin and the nitration of
other human proteins, the effect of nitration on critical bioactivity functions of LF has not
been studied. Here the study presents experimental results that show for the first time that
peroxynitrite-induced nitration of LF reduces the antibacterial properties of the protein.
This nitration presents an overview of changes in LF secondary structure as measured by
circular dichroism (CD) spectroscopy and show a reduction in iron-binding capacity after
38

LF nitration. This study also suggests possible links between changes in the secondary
protein structure and observations about reduced antibacterial activity.
3.3 Experimental
3.3.1 Materials
Human milk lactoferrin (LF; L0520), sodium phosphate dibasic (RES20908A702X), potassium chloride (P9333), sodium chloride (S9625), potassium phosphate
monobasic (P5655), Iron(III) chloride hexahydrate (FeCl3.6H2O; 236489), Nitrilotriacetic
acid (NTA; N9877), Trizma base (Tris-HCl; T1503), Hydrochloric acid (H-7020),
Tryptic Soya broth (TSB; 22092), Chloramphenicol antibiotic (CAM; C0378), and
Tryptic Soya agar (TSA; 22091) were obtained from Sigma Aldrich (USA). Sodium
peroxynitrite (NaONOO; 516620), Amicon Ultra-0.5 centrifugal filters (30 kDa, 0.5 mL
volume; UFC503008), and Amicon Ultra-4 centrifugal filters (30 kDa, 4 mL size;
UFC803024) were obtained from Calbiochem (USA). 100 mm x 15 mm petri dish with
grip ring (sterile; 229692) were obtained from CELLTREAT (USA). Flat-bottom, 96microwell plates (untreated; 333-8013-01F) and sterile sealing tape (ST-3095) were
obtained from Life Science Products (USA). UV, 96-microwell plates with transparent
flat bottom (3635) were obtained from CORNING (USA). Escherichia coli (E. coli;
ATCC25922) were obtained from the American Type Culture Collection (USA).
Buffers and iron solution were prepared as follows: phosphate-buffered (PB; 0.1
mM sodium phosphate dibasic and 0.5 M sodium phosphate monobasic at pH 7.4),
phosphate-buffered saline (PBS; 8.1 mM sodium phosphate dibasic, 0.8 mM sodium
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phosphate monobasic, 1.3 mM potassium chloride, and 68.0 mM sodium chloride at pH
7.4), Tris-HCl buffer (Tris; 50 mM at pH 4.0, 150 mM sodium chloride ,20 mM sodium
carbonate and 71.0 mM sodium bicarbonate at pH 7.4), ferric nitrilotriacetic acid
(Fe(NTA)2) solution (FeCl3.6H2O 4.0 mM and NTA 8.0 mM and 1 N HCl add 2% to
total solution volume at pH 4.0). Tryptic soya broth and tryptic soy agar were prepared
following the manufacture instructions.
3.3.2 Nitration of lactoferrin by alkaline peroxynitrite (ONOO-)
Samples of nitrated lactoferrin were prepared for the iron-binding assays
following the procedure described by Alhalwani et al. (Alhalwani, et al. 2018) Briefly,
the reaction was prepared in 96-microwell UV-plates by adding 100 µL aliquots of 10.0
mg mL-1 (± 5%) human milk LF in aqueous solution into each well, then adding
NaONOO to each well in two different amounts (5.66 and 22.73 µL) corresponding to
peroxynitrite to tyrosine (ONOO-/Tyr) molar ratios of 10/1 and 40/1. The volume of TrisHCl buffer added to each solution was matched with the volume of NaONOO added in
order to make a total volume of 200 µL and a NLF concentration of 5.0 mg mL-1 (± 5%).
The microwell plate was set on ice for 120 min. The product of nitration reaction was
purified using a micro-centrifugal filter device (0.5 mL) and rinsed twice with nanopure
water.
Samples of NLF were prepared for the antibacterial assay, following above
procedure, but replacing PBS buffer for Tris-HCl buffer. The buffer used for each assay
was chosen to optimize assay results. Tris-HCl was chosen for the iron-binding tests to
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properly dissolve Fe3+, whereas PBS was used for the antibacterial assay as standard
physiological buffer mimic that is non-toxic to the bacterial cells.
3.3.3 Broth antibiotic susceptibility assay to test antibacterial function
The protocol used here generally followed procedures outlined by Wiegand et al.
for the minimum inhibitory concentration assay, with some modifications (Wiegand, et
al. 2008). Briefly, E. coli was prepared by suspending the entire volume of the purchased
bacterial powder in 5 mL of broth. After 24 hrs of incubation, 1 mL of this broth was
mixed 1:1 with glycerol to produce the glycerol stock of E. coli that was stored up to long
term for many years at ca. -80oC. When ready, a 1 µL aliquot of the glycerol stock of
bacteria was incubated in TSA plates at 37ºC for 24 hrs. Subsequently, three to five
separate colonies from each plate were selected and transferred into 4 mL TSB and
incubated at 37ºC for 24 hrs. After incubation, the 4 mL solutions of growth media were
diluted to approximately 10% of the original concentration by adding 36 mL of TSB,
subsequently referred to here as E. coli broth stock. 200 µL aliquots of broth stock were
then placed into each microwell. Five separate sample types were prepared: assay blank
using TSB and no bacteria, positive control with bacteria in 30 µg mL-1 CAM, and,
bacteria in 1 mg mL-1 concentrations, separately, of LF, 10/1 NLF, and 40/1 NLF. 5 µL
of E. coli broth stock was added to each well and incubated at 37ºC overnight. Finally,
the absorbance of each well was examined at a wavelength of 600 nm using a plate reader
(Tecan Infinite, M1000 PRO) with 5.0 nm incident bandwidth.
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3.3.4 Circular dichroism assay to determine the secondary structure
CD spectra were recorded using the Jasco Model J-810 spectro-polarimeter using:
a 1.0 mm path length quartz cell for absorption in the far-UV region (190 – 250 nm), scan
speed of 20 nm/min, bandwidth of 1.0 mm, digital integration time of 4 sec per nm, and
data pitch 1 nm. LF and NLF samples were diluted in PB buffer for analysis. Dilution
calculations were performed using the molecular mass of LF, irrespective of the minor
change in mass due to nitration.
3.3.5 Preparation of iron-bound lactoferrin and detection of iron concentration
The iron-loading assay was prepared following procedures outlined by Hamilton
et al. (Hamilton, et al. 2009). After nitration reaction samples were purified, each
UV-microwell was coated with 200 µL of either LF, 10/1 NLF, or 40/1 NLF. To
each well, 20 equivalents of Fe(NTA)2 were added, and the absorbance was measured
using the plate reader after 45 minutes of waiting at room temperature and then analyzed.
The absorbance of each well was detected using the plate reader at wavelength 470 nm.
The ferrozine method was used to determine the iron uptake following a method
reported by Stookey et al. (Stookey 1970). The protein concentration was measured using
the Bradford assay. 100 µL samples consisting of 19.0 µM of each protein were
diluted into nanopure water. A blank consisting of only water was also prepared. 10 µL
of 3 M of trichloroacetic acid was added to each sample and centrifuged at 14000 g for
12 min. The supernatant from each sample was collected and mixed with 330 µL of
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nanopure water, 20 µL of 10 mM ferrozine, and 20 µL of saturated sodium acetate.
Each mixture was analyzed at absorbance 562 nm (ε 27.9 mM-1 cm-1).
3.3.6 Data analysis
Igor Pro 7 software (Wavemetrics, Inc.; Oregon, USA) was used to analyze
results. Bacterial cultures were grown in replicates three to five, each culture referred to
as an individual experiment. All assay measurements were also performed at a minimum
of triplicates of technical replicates, i.e. three wells individually prepared. For
experiments involving bacterial cultures, values were first averaged from technical
replicates and are represented here as averages of individually cultured experiments. Data
shown represent mean ± standard deviation (s) of data values. Results were
subjected to t-tests, including associated p-values calculated using the unpaired ttest function in Microsoft Excel (i.e. ttest (Series1, Series2, 1,2)).
The protein secondary structures of CD samples were analyzed using βStructure Selection (Bestsel) software available as online freeware (Micsonai, et al.
2015).
3.4 Results
3.4.1 Broth antibacterial assay for LF
The broth antibacterial susceptibility assay has previously been used to measure
the minimum inhibitory concentration by using a visible measure of bacterial growth to
determine the lowest concentration at which an antimicrobial agent was effective against
a certain bacterial species (Wiegand, et al. 2008). Here the broth type was modified and
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the protocol was applied to quantify the inhibitory effect of LF and nitrated LF (NLF)
against E. coli growth. Samples of E. coli were incubated separately under five conditions
to first demonstrate the antibacterial activity of LF and to test the optimized assay
conditions. Figure 3. 1 shows the relative density of bacterial cell number as the
absorbance of the suspension measured at 600 nm. Growth inhibition is thus related by
the reduction in absorbance compared to the negative control (E. coli only) samples. The
blank (no E. coli) is defined as no growth. Chloramphenicol (CAM), used as strong
antibiotic, shows near complete inhibition of growth, and LF shows partial inhibition at
each protein concentration. Experimental concentrations of LF were chosen to match the
approximate range present in ocular tear fluid in the normal eye (~2.0 mg mL-1) and
during ocular disease (<2.0 mg mL-1) (Ballow, et al. 1987). Results confirm that the
optimized assay shows increasing E. coli growth inhibition with increasing concentration
of added LF, as was previously shown by Kutila et al. over a range 0.7 – 2.7 mg mL-1
(Kutila, et al. 2003).
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Figure 3. 1 Optimized antibacterial assay. Absorbance at 600 nm shown for blank (broth,
no E. coli), CAM (positive control, strong inhibition), E. coli (negative control, no
inhibition) tested against LF at three concentrations: 0.5, 1.0, and 2.0 mg mL-1. Bars
show mean values ± standard deviations of three individually cultured experiments.
Absorbance values shown without blank subtraction.
3.4.2 Antibacterial activity of LF and NLF
The optimized broth antibacterial assay was subsequently used to determine the
antibacterial activity of nitrated lactoferrin (10/1 and 40/1 molar ratios of nitrating agent
to LF) compared to unmodified LF against E. coli.
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Figure 3. 2 shows that LF inhibited E. coli growth by LF to be ca. 12%. In
contrast, both concentrations of NLF show no inhibitory effect with respect to E. coli.
Antibacterial inhibition tests show that 10/1 and 40/1 NLF exhibit p-values of <0.00005
and <0.005 when compared to cultures treated only with LF. Further, both NLF cultures
show growth properties to be insignificantly different (ns) from E. coli cultures grown
without any kind of LF or NLF treatment. These results suggest that modifying the LF
through nitration at molar ratios of both 10/1 and 40/1 was sufficient to remove all of the
antibacterial benefits presented by the unmodified protein.

Figure 3. 2 Antibacterial activity of LF vs. NLF. Absorbance at 600 nm shown for blankcorrected absorbance values for E. coli grown against LF, 10/1 NLF, and 40/1 NLF (1.0
mg mL-1 each). Bars show mean values ± standard deviations of five individually cultured
experiments. Absorbance value for each experiment averaged from measurements of four
technical replicates. P-values show statistical significance of differences in inhibition
with respect to LF and E. coli, respectively; ns - not statistically significant.
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3.4.3 Secondary protein structures of LF and NLF
To investigate conformational changes in the secondary structure of LF before
and after nitration, four samples of LF, with and without nitration and with and without
bound Fe3+, were analyzed using CD spectroscopy. The far-UV wavelength range (i.e.
190-250 nm) probed by CD spectroscopy reveals information about the folding properties
of the protein through its secondary structure (Kelly, et al. 2005). Three CD spectra of
each sample were averaged and are shown in Figure 3. 3.
The spectral minima for LF shifted approximately 10 nm to lower wavelength
upon nitration (red → blue traces) for both the apolactoferrin (iron-free) and
hololactoferrin (iron-bound) samples. The secondary structures associated with the
protein samples were then analyzed using the Bestsel online software (Micsonai, et al.
2015). As expected from its crystal structure (Anderson, et al. 1989a), the measured CD
spectrum of lactoferrin confirms it to be a well-folded protein of primarily alpha-helical
character (Figure 3. 3). Iron binding was found to not significantly change the spectra in
the cases of either LF or NLF.
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Figure 3. 3 Secondary protein structure via circular dichroism spectroscopy. CD spectra
of LF (red solid trace), 10/1 NLF (blue solid trace), LF-Fe (red dashed trace), and 10/1
NLF-Fe (blue dashed trace) acquired between 190 and 250 nm. Spectra shown as
averages of three readings. Y-scales independently scaled to highlight overlap of
spectra.3.4.4 Iron-binding ability of LF and NLF
To examine the ability of the protein to bind iron, samples of LF and NLF were
subjected to two iron-binding assays. In the case of NLF, Fe3+ was added to the samples
after nitration reactions were complete. Results from both assays qualitatively show a
reduction in the ability of LF to bind iron after nitration, with increasing effect from
increased molar ratio of nitrating agent (Table 3. 1).
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Table 3.1 Iron determination data. LF and NLF samples listed as blank-subtracted values.
Relative reduction in iron capacity shown in parentheses for NLF samples with respect to
LF.

Ferrozine Assay

Iron Loading

(µM)

Assay (A)

Blank

0.38

0.031

LF

25.5

0.072

NLF 10/1

22.0 (-13%)

0.010 (-74%)

NLF 40/1

19.1 (-24%)

-0.006 (-110%)

Sample

3.5 Discussion
The relationship between LF concentration and bacterial inhibition was shown
here to exhibit approximately linear behavior (Figure 3. 1), consistent with observations
shown by Ellison et al. (R. T. Ellison, et al. 1988). A reduction in the antibacterial
activity of LF upon nitration had not been previously observed, however. Inhibition of
the antibacterial activity is consistent with charge-related properties of the interaction
between E. coli and LF. Gram-negative bacteria can generate inflammatory mediators
such as LPS bound within the outer bacterial membrane, and these mediators can induce
cytotoxicity in humans (Heumann, et al. 2002). LF proteins within human fluids act to
protect against the toxic effects by binding to LPS and thus damaging the bacterial
membrane (Lönnerdal, et al. 1995). The mechanism by which LF kills gram negative
bacteria has previously been shown to proceed via binding of bacterial membrane porins
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by cationic regions of LF concentrated at the N-terminus (Bellamy, et al. 1992; Erdei, et
al. 1994). Nitration has been shown to add anionic nature to protein structure (Ignarro, et
al. 1995). For example, the reaction of LF with ONOO- adds nitro groups (NO2) to
aromatic amino acid residues such as tyrosine (Alhalwani, et al. 2018), thereby increasing
the anionic charge of the protein. The corresponding decrease in cationic surface
properties of the protein would thus be expected to reduce the binding of LF to LPS,
leading to a decrease in the antibacterial properties of LF qualitatively consistent with the
results shown in Fig. 3. 2.
Separate from the ionic properties of LF that affect bactericidal activity, the
secondary structure of native LF is critical to its antibacterial function (Japelj, et al.
2005). Teuwissen et al. showed that nitration of apolactoferrin using tetranitromethane
(TNM) changed the tertiary protein structure sufficiently to reduce its ability to uptake
iron (Teuwissen, et al. 1973). TNM is not a physiologically relevant nitrating agent,
however, and so the extrapolation of effects within the body is not obvious. It was also
previously shown that ONOO- present at physiologically relevant concentrations can
efficiently nitrate LF (Alhalwani, et al. 2018). The secondary structure of LF has
separately been investigated many times using CD spectroscopy (Kang, et al. 1996a),
however, no previous reports had shown changes in LF structure associated with ONOOnitration. Here we showed for the first time that LF nitration induced by ONOO- can
cause significant changes to the protein structure (Fig. 3. 3). Quantification of structural
properties using the Bestsel online software (Micsonai, et al. 2015) suggests that LF
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undergoes a drop in both the alpha-helical and beta-parallel sheet character upon
nitration. Similarly, LF nitrated after saturation with Fe3+ resulted in a drop in alphahelical character by approximately half. Nitration of lactoferrin in both unligated and
iron-bound cases thus causes significant changes in secondary structure that suggests
partial protein unfolding. The LF nitrated without bound iron, however, shows relatively
greater reduction in the alpha-helical spectral region than iron-bound LF. This may
suggest that the bound Fe3+ stabilizes the protein and also protects against nitration of the
two tyrosine residues in each binding site. These possibilities will need to be probed in a
future study.
Our observations conceptually match results for a structurally similar protein
alpha-Crystalline, shown to exhibit misfolding after nitration with ONOO- (Thiagarajan,
et al. 2004). Several studies have shown that alpha-helical peptides from LF provide
bactericidal activity against E. coli. (Chapple, et al. 1998; Håversen, et al. 2000). Elass et
al. also showed that LPS in E. coli interacted with the alpha-helical region of LF peptides
and caused membrane damage (Elass-Rochard, et al. 1995). Here we showed a reduction
in the CD spectral band in alpha-helix regions (208 and 222 nm). Together, the
complementary observations suggest that nitration within the alpha-helical structure of
the LF protein is likely to partially explain the reduction in antibacterial activity for NLF.
A separate test of iron-binding ability for both LF and NLF samples showed a
qualitative decrease in iron uptake after nitration. These tests will need to be duplicated at
a broader range of protein concentrations, to establish a higher degree of statistical
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significance, and to quantitatively calculate iron binding constants. The initial evidence
shown, however, is suggestive that iron uptake by LF is diminished upon nitration.
The observations here are the first to show that NLF exhibits reduced antibacterial
activity compared to native LF. These results have critical relevance to nitration
pathways within the human body as a function of inflammation and environmental
exposure. For example, ONOO- levels have been shown to increase dramatically during
eye inflammation (Allen, et al. 1998), which suggests that proteins such as LF in ocular
fluids are likely to exist in at least partially nitrated states. LF converted to NLF in these
nitrosative environments are thus likely to increase the possibility of bacterial infection,
which can dramatically exacerbate ocular stress. The exposure of proteins within ocular
fluid and in mucous membranes of the lungs and nasal passages can also be exposed to
nitration through interaction with urban pollutant gases such as NO2 and O3 (Shiraiwa, et
al. 2012). Protein nitration reactions have been proposed to provide a mechanism by
which allergic and toxic responses are increased. Our observations thus represent a
possible link to biochemical modification pathway during diseases and due to
environmental exposure.
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Chapter four: Ergothioneine inhibits nitration of proteins and can enhance natural
antibacterial activity
4.1 Abstract
Ergothioneine (Ergo) is a natural product compound with antioxidant activity. It is
accumulated in high concentration in many mammalian tissues including the eye. Ergo
decreases in concentration within aging adults and may correlate with the presence of
aging-related disease (Cheah, et al. 2016). This study was to investigate the Ergo
contribution to protecting several proteins from nitration effects. The nitration reactions
were applied using ONOO- and TNM nitration agents with and without the presence of
Ergo. The nitration products were analyzed using absorbance and fluorescence
spectroscopy and were compared with respect to non-nitrated proteins. The quantification
of the nitrotyrosine level was also detected via the ELISA technique. The antibacterial
function of nitrated lactoferrin was tested by broth microplate antibacterial assays. Our
results show that Ergo exhibits anti-peroxynitrite activity by reducing nitration, and Ergo
exhibits anti-inflammatory activity by restoring the antibacterial activity. This
investigation will play a role for Ergo in prevent oxidative and nitrosative ocular damage.
4.2 Introduction
There are many nitration inhibitors, including ergothioneine (Ergo). Ergo has
other unique properties aside from nitration inhibition. Ergo has a relatively small
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molecular weight of approximately 229 Da (Hartman 1990) , is a safe, natural product
compound, is odorless, is colorless, does not autoxidize, has high solubility in aqueous
solutions up to 0.9 M, is stable, and degrades slowly in the physiological system.
Ergo is synthesized in fungi and mycobacteria, but there is no evidence for
presence of biosynthesis in mammals or higher plants (Melville, et al. 1954). It is
accumulated in several parts of the human body in concentrations of 1.0-2.0 mM such as
lens of the eye, the cornea, the liver, and in bone marrow (Melville, et al. 1954). The
presence of a high level of Ergo in mammalian ocular tissue has previously been
determined, suggesting that it accumulates after being eaten (Shires, et al. 1997).
Ergo has many functions (Cheah, et al. 2012); as an antioxidant, as an Ergo tumor
necrosis factor (TNF-α), as a hydrogen peroxide (H2O2) inhibitor in alveolar epithelial
cells (Rahman, et al. 2003). As an anti-peroxynitrite agent, Ergo inhibits peroxynitritedependent reactions and protects tyrosine from nitration (Aruoma, et al. 1997). As an
anti-inflammatory, Ergo inhibits xanthine and hypoxanthine formation (Žitňanová, et al.
2004). The multifunctionality of Ergo shows the possibility for therapeutic usage in many
diseases, such as cardiovascular diseases (Servillo, et al. 2017) and acute respiratory
distress (Repine, et al. 2012). Ergo is a well-known anti-peroxynitrite, anti-oxidant, and
anti-inflammatory substance (Franzoni, et al. 2006b; Cheah, et al. 2012). One of the main
Ergo antioxidant mechanisms is the capture of free radicals such as hydroxyl radical, and
peroxynitrite. To my knowledge there is no reported mechanism in arrow reaction for
Ergo functions has been done.
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The aim of this work is to investigate the nitration inhibition effect of Ergo using
several nitrated proteins samples; bovine serum albumin, lactoferrin, and lamb cornea
lysate. Described here are several techniques used to examine Ergo’s inhibition activity,
including ELISA and spectroscopy techniques. Also shown is the broth antibacterial
assay used to examine LF’s antibacterial activity.
4.3 Experimental
4.3.1 Materials
Ergothineine (Ergo, 26524) were obtained from OXIS international, Inc. Human
milk lactoferrin (LF; L0520), bovine serum albumin (BSA; A7030), tetranitromethane
(TNM; T25003), Tween®20 buffer (P1379), Trizma base (Tris-HCl; T1503), sulfuric
acid (H2SO4; 320501), sodium phosphate dibasic (RES20908-A702X), potassium
chloride (P9333), sodium chloride (S9625), potassium phosphate monobasic (P5655),
sodium carbonate (S7795), sodium bicarbonate (S5761), glysrol (G9012), and ethanol
(245119), 4-(2-Hydroxyethyl) piperazine-1-ethanesulfonic acid, N-(2-Hydroxyethyl)
piperazine-N′-(2-ethanesulfonic acid) (HEPES; H3375), Triton X-100 (X100),
ethylenediaminetetraacetic acid anhydrous, bioultra (EDTA), chloramphenicol antibiotic
(CAM; C0378), Trizma base (Tris-HCl; T1503), Hydrochloric acid (H-7020), Tryptic
Soya broth (TSB; 22092), and Tryptic Soya agar (TSA; 22091) and sodium chloride
(S9625) were purchased from sigma-aldrish (USA).
HALT (tm) protease inhibitor (PI; QB203967A) from fisher scientific company
(PA, USA). Sodium peroxynitrite (NaONOO; 516620), Amicon Ultra-0.5 centrifugal
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filters (30 kDa, 0.5 mL size; UFC503008) and Amicon Ultra centrifugal filters (30 kDa, 4
mL size; UFC803024) were purchased from Calbiochem (USA).
The 1-step ultra 3,3’,5,5’-tetramethylbenzidine substrate (TMB; 34028) and
bicinchoninic acid assay (BCA; 23225) for total protein quantification were purchased
from ThermoFisher Scientific (USA). Flat-bottom, 96-microwell plates (untreated; 3338013-01F) and sterile sealing tape (ST-3095) were obtained from Life Science Products
(USA). A biotinylated, mouse monoclonal to nitrotyrosine antibody (α-NTyr; ab24496),
streptavidin horseradish peroxidase (HRP; ab7403), and non-conjugated goat polyclonal
anti-human lactoferrin antibody (α-LF; ab77548) were obtained from Abcam (UK). 1.0
mL quartz cuvette with 10mm path length (MF-W-10-LID) was purchased from Science
Outlet (USA).
Biotinylated, mouse monoclonal to nitrotyrosine antibody (α-NTyr; ab24496),
non-conjugated goat polyclonal anti-human lactoferrin antibody (α-LF; ab77548), and
streptavidin horseradish peroxidase (HRP; ab7403) were obtained from Abcam (UK).
100 mm x 15 mm petri dish with grip ring, sterile (229692) provided by CELLTREAT
(USA). UV 96-microwell plate with a transparent flat bottom (3635) was purchased from
CORNING (USA).
Escherichia coli (E. coli; ATCC25922) was purchased from the American Type
Culture Collection, ATCC (USA). Lamb cornea (age: 3 months, male gender) was
donated from local butcher store (Jerusalem Market, E. Illif Ave.), it was FDA approved
for human consumption and handling.
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Buffers used were: phosphate-buffered saline (PBS; 8.1 mM sodium phosphate
dibasic, 0.8 mM sodium phosphate monobasic, 1.3 mM potassium chloride, and 68.0 mM
sodium chloride at pH 7.4), Tris-HCl buffer (Tris; 0.1 mM at pH 8.0), carbonate buffer
(29.0 mM sodium carbonate and 71.0 mM sodium bicarbonate at pH 9.6), tryptic soy
broth, and tryptic Soy agar was prepared following the manufacture instructions,
and extraction buffer (EB) solution (50.0 mM Tris-HCl, 10.0 mM HEPES, 150.0 mM
NaCL, 5.0 mM EDTA, 0.5 % Triton at pH 7.7, and then fresh add 10 % protease
inhibitor (PI) and Tris-HCl buffer (Tris; 50 mM at pH 8.0).
The volume of peroxynitrite used for production of NLF10/1 ONOO- sample
discussed in Section 4.4.2 was 5.66 µL. Similarly, the volume of TNM used for
production of NLF10/1TNM discussed in Section 4.4.2 was 0.29 µL. The volume of
tetranitromethane used for production of NBSA6/1 discussed in Section 4.4.1 was 0.95
µL of 6/1. The volumes of (17.05 µL) peroxynitrite and (1.16 µL) tetranitromethane used
for production of nitrated cornea lysate ONOO- and TNM samples. These values correspond
to molar ratios of nitrating agent to tyrosine (ONOO-/Tyr) or (TNM/Tyr).
Proteins samples were tested: (1) BSA, NBSA 6/1(TNM), NBSA6/1(TNM)Ergo 0.1 and 1.0 mM, (2) LF, NLF10/1(TNM), NLF10/1(TNM)- Ergo 0.1 and 1.0
mM, (3) LF, NLF10/1(ONOO-), NLF10/1(ONOO-)-Ergo 0.1 and 1.0 mM,(4) cornea
lysate, nitrated cornea lysate (TNM), and nitrated cornea lysate (TNM)- Ergo 5.0 mM,
and (5) cornea lysate, nitrated cornea lysate (ONOO-), and nitrated cornea lysate
(ONOO-)-Ergo 5.0 mM.
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4.3.2 Protein nitration reaction
The nitration reactions protocol followed procedures outlined by Alhalwani et al.
to produce nitrated BSA, nitrated LF, and nitrated cornea lysate using TNM or ONOO(Alhalwani, et al. 2018). Briefly, TNM reaction occurs in a mixture of Tris-HCl buffer
and 20% ethanol, followed by added TNM volume based in a preferred TNM/Tyr molar
ratio and serried at RT for 3 hours. The ONOO- reaction occurs in PBS buffer at a
preferred ONOO-/Tyr molar ratio and serried in ice for 3 hours. Then, each nitration
model (TNM or ONOO-) has two nitration groups, one group with Ergo and another
group without Ergo. Ergo was added to the protein before adding the nitration agents to
work efficiently in protecting the protein from nitration modification. The nitration
reaction for cornea lysate was performed by adding the same concentration of each
nitration agent.
The nitration product was purified using Amicon centrifugal tube and the protein
was quantified using BCA assay following the manufacturer's protocol. Instruments
were used; UV-vis spectrophotometer (Cary BIO 100), fluorimeter (Carry eclipse),
rocking platform (UltraRocker, BIO-RAD), and plate reader (Tecan Infinite, M1000
PRO).
4.3.3 Absorbance analysis
The UV-Vis analysis used wavelength range of 250-500 nm and 2 nm steps
obtained the absorption spectra. The protein samples were analyzed at RT using a
100 mm quartz cuvette. The concentration of the samples was consistent and diluted in a
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reaction buffer PBS or Tris-HCl. The dilution of protein samples was calculated
based on the molecular mass of native protein, irrespective of mass changes due to
nitration.
4.3.4 Fluorescence analysis
The fluorescence analysis used excitation wavelength at 280 nm which is related
to higher fluorescence of tyrosine and tryptophan. The fluorescence detected in a 2 nm
increment at RT using a 10.0 mm quartz cuvette. Sample concentrations were 0.2
mg/mL and diluted in a proper reaction buffer PBS or Tris-HCl. The result shows a
correlation between excitation wavelength and the corresponding emission intensity. The
fluorescence spectra were used to determine the difference between the chemical
structure properties and the native, nitrated protein, and nitrated protein-Ergo.

4.3.5 (NTyr) Direct enzyme linked immunosorbent assay (ELISA) to determine
nitrotyrosine level
To detect the differences in nitrotyrosine between protein samples, direct ELISA
was used to quantify the nitrotyrosine residue in the following samples: NBSA
6/1(TNM), NBSA 6/1(TNM)- Ergo 0.1 and 1.0 mM, Cornea lysate, nitrated
lysate(TNM)- Ergo 5.0 mM, and nitrated lysate(ONOO-)-Ergo 5.0 mM. BSA was used
because it is a standard protein and has 21 tyrosine residues, which is similar to the 20
tyrosine residues in LF.
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Here, samples were diluted into a carbonate buffer at concentration 5 µg mL-1.
The samples were coated in triplicate with each sample solution and added separately to
three wells as a blank measurement. The plate was covered with tape and incubated at RT
for 2 hours. Washing steps to each well was applied after the incubation using 200 µL of
PBST (PBS with 0.05% Tween) followed by patting the plate with a laboratory wipe to
take away the extra washing buffer, repeated twice. This step was repeated after each
incubation step with the same process of covering and plate shaking while incubation
time using a rocking platform and then washing steps using PBST.
After washing, the plate was blocked by the non-specific binding areas using 200
µL of blocking buffer (5% BSA in PBS). This was added to each well and incubated at
RT for 2 hours. Following the washing step, mouse monoclonal to nitrotyrosine
biotinylated antibody (α-NTyr) was diluted in blocking buffer in 1:500 dilution ratio and
50 µL of the dilution was added to each well and incubated at RT for 1 hour. After that,
streptavidin-HRP diluted 1:10,000 in blocking buffer was added in 50 µL to each well
and incubated at RT for 1 hour. The TMB substrate was added in 100 µL to each well
and incubated at RT until the color developed from colorless to blue in about 10 minutes.
The 0.5 N aqueous sulfuric acid was added in the top of the substrate and the color
quickly changed to yellow.
The plate was measured using the optical absorbance of each well using a
microwell plate reader. The measurement was based on standard procedures

61

(Rajasekariah, et al. 2003). The final absorbance is a value of the subtracted background
wavelength 620 nm (blue) from the wavelength at 450 nm (yellow).
4.3.6 (LF- NTyr) Sandwich ELISA for quantify nitrotyrosine
The sandwich ELISA protocol was followed by Alhalwani et al.(Alhalwani,
et al. 2018) which is a unique combination of antibodies which are that the
captured antibody was goat polyclonal to lactoferrin non-conjugated antibody (αLF), and the detector antibody was mouse monoclonal to nitrotyrosine biotinylated
antibody (α-NTyr) to detect nitrotyrosine in LF molecules.
The microplate was coated with 50 µL of 1:1000 dilution ratio of captured
antibody in carbonate buffer at at 4°C overnight. The plate was then washed and
blocked as described above. After the washing step, 50µL of NLF10/1(TNM),
NLF10/1(TNM)- Ergo (0.1 and 1.0 mM), NLF10/1(ONOO-), and NLF10/1(ONOO-)Ergo (0.1 and 1.0 mM) that were diluted into the blocking buffer to produce NLF
solutions of concentrations 5 µg mL-1 and added in triplicate to the plate and
incubated at RT for 1 hour. Blocking buffer was used for blank measurements. The
detector antibody diluted in blocking buffer was added in 50 µL of 1:100 dilution
ratio and the plate was incubated with shaking at RT for 1 hour. The enzyme
streptavidin-HRP and the substrate TMB were added following the ELISA protocol,
as described above. The standard calibration curve was made according to the
absorbance at each concentration of 40/1 molar ratio NLF.
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4.3.7 Broth microplate antibacterial assay to detect the antibacterial activity
The assay was followed by broth microplate antibacterial assay in previous study
(Jorgensen, et al. 2015; Balouiri, et al. 2016). E. coli broth stock was prepared from 1 µL
of glycerol stock aliquot of E. coli was inculcated into TSA plates at 37 ºC for 24 hrs.
Then, several (3-5) separate colonies were selected, transferred into 4 mL TSB, and
incubated at 37 ºC for 24 hours. Finally, the 4 mL of E. coli in TSB was diluted 10%
dilution by adding 36 mL of TSB to make E. coli broth stock.
In the microplate, TSB (200 µL) was added with the samples. All samples were
prepared in TSB, (Blank) using TSB, (positive control) in CAM in 30 µg mL-1, LF, Ergo,
NLF (ONOO-)10/1-Ergo 0.2, 1.0, 5.0 and 10.0 mM, and NLF (ONOO-) 10/1, 20/1,
30/1, and 40/1 Ergo 5.0 mM all NLF’s samples were in 1.0 mg mL-1concentrations.
In each well, 5 µL of E. coli broth stock was added and incubated overnight at 37 ºC. The
microwell plates were examined at wavelength 600 nm using the plate reader.
4.3.8 Lamb cornea tissue dissection
The lamb cornea was extracted from the whole lamb eye using a surgical razor
blade. Then, the cornea was cut into four pieces, weighted using an analytical scale, and
followed by a snap freeze using liquid nitrogen. The cornea was placed in a cryogenic
microtube and stored at -80°C until extraction occurs, see appendix B.
4.3.9 Protein extraction from lamb cornea
The cornea was washed using Tris-HCl buffer and placed into the extraction
buffer 10% tissue mass per volume. The mixture was mixed in ice for 25 minutes and
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sonicated at 8 powers for 2 minutes. Finally, the mixture was centrifuged at 1400 g for 30
minutes and the supernatant was collected and aliquot in cryogenic microtube and stored
at -20°C until further analysis. The total protein in the lysate was detected using BCA
assay following the manufacture protocol.
4.3.10 Statistical analysis
All data were analyzed using Igor Pro 7 software (Wavemetrics, Inc.;
Oregon, USA). All ELISA and bacterial samples were run in triplicate, averaged, and
represented mean ± standard deviation (s) of data values. Analyses of variance were
subjected to t-tests, including associated p-values performed using GraphPad
software.
4.4 Results and Discussion
4.4.1 Nitrated standard protein NBSA 6/1(TNM) used to characterize nitration
inhibition via Ergo
The TNM nitration reaction was used to produce nitrated protein with the highest
NTyr residues since the nitration reaction by TNM reagent mainly produce NTyr residues
in the protein. An Ergo concentration of 1.0 mM was used as an effective inhibitory
concentration against NTyr formation as has been shown in previously published reports
(Aruoma, et al. 1997) Addionally, the NTyr formation was tested to detect the effective
dose of inhibition using sandwich ELISA which confirm this concentration. The result of
Sandwich ELISA shows the correlation between the reduction of NTyr formation and
Ergo concentration which are Ergo 1.0, 5.0, and 10.0 mM; see Figure 4.1.
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Figure 4. 1 Sandwich ELISA for NLF 10/1 and Ergo. The NLF 10/1 shows similar NTyr
formation at Ergo 1mM and higher concentrations.
The NBSA 6/1(TNM) was used to test inhibitory effects of Ergo against
nitration, (Figure 4. 2) using three analytical methods. Absorbance intensity at 350 nm
obtains information about the nitration formation through the increase in nitrated product
absorbance. The spectra of NBSA 6/1 (Figure 4. 2. A) showed higher absorbance
intensity than NBSA with Ergo. The decrease in absorbance band indicates the inhibition
effects of Ergo to nitration formation. Additionally, the fluorescence intensity at
excitation 280 nm identifies the nitration formation by diminishing the intensity. The
fluorescence spectra of NBSA 6/1 showed lower fluorescence intensity than NBSA with
Ergo (Figure 4. 2. B). The increase in fluorescence band shows the inhibition effects by
Ergo. Nitrotyrosine (NTyr) is a marker for the nitration formation and to determine the
Ergo effects, the level of NTyr residue in the samples needs to be monitored. The direct
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ELISA quantifies nitrotyrosine residues which indicate the nitration formation. The result
of NBSA 6/1 (Figure 4. 2. C) detected higher NTyr concentration than NBSA with Ergo.
The three analyses each suggest that NBSA 6/1 has the highest nitration formation
comparing to NBSA 6/1-Ergo 0.1 and 1.0 mM. These results together confirmed the
inhibition effects of Ergo to the nitration. There was a direct correlation between the Ergo
concentration and the nitration inhibition e.g. NBSA 6/1-Ergo1.0 mM had less nitration
than NBSA 6/1-Ergo 0.1 mM. Our results are consistent with the study by Aruoma et
al.(Aruoma, et al. 1997) that showed the association between the decrease in
nitrotyrosine residues to the increase of the concentration of Ergo. Here, we used NBSA
6/1 as standard protein to help in adjusting the analysis for our target protein LF and
cornea lysate.

Figure 4. 2 The results of the effect of Ergo in NBSA 6/1. Three data sets presented are
A: absorbance (blue mark), B: fluorescence (red mark), and C: direct ELISA n=3 (green
mark) showed the nitration chemical properties with respect to Ergo effects. In each
graph, the samples presented at x-axis were from right to left were NBSA 6/1(TNM),
NBSA 6/1(TNM)- Ergo 0.1, and NBSA 6/1(TNM)- Ergo 1.0 mM.
4.4.2 Nitrated human protein NLF10/1 used to test Ergo inhibitory property
Herein, we nitrated lactoferrin using two models; TNM to produce mainly 3nitrotyrosine (NTyr ) and as nitration exogenesis model, and ONOO- to produce several
nitrated amino acids and as nitration endogenous model. The NLF10/1 used as a positive
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control for the nitration formation and to compare it with the samples of NLF10/1with
Ergo.
The spectroscopic results (Figure 4. 3. A and B) showed an increase in
absorbance intensity at 350 nm and a decrease in the fluorescence intensity at excitation
280 nm for NLF10/1 and these effects inverted after the addition of Ergo. The result of
NLF10/1 with TNM was consistence to NLF10/1 with ONOO-. The results of NLF and
NBSA confirmed the Ergo inhibitory effects against protein nitration. In our previous
study, we developed a specific sandwich ELISA that detects NTyr in nitrated lactoferrin
samples (Alhalwani, et al. 2018), thus, the level of NTyr residues were determined using
this sandwich ELISA. The sandwich ELISA quantifies nitrotyrosine residues (Figure 4. 3.
C) which confirm the nitration formation. The NLF10/1 showed higher NTyr residues
than NLF10/1 with Ergo.
The results of NLF10/1 with Ergo showed a decrease in NTyr residues with the
increase of Ergo concentrations. This finding suggests that Ergo protects lactoferrin
protein from nitration. By contrast, the link in both nitration agents ONOO- or TNM is to
produce NO2 in the reaction environment and cause protein nitration. We observed that
NLF with ONOO- or TNM has similar inhibition response via Ergo. This observations
lead to the possible Ergo inhibition mechanism by capturing an NO2 molecule to prevent
lactoferrin from the nitration process.
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Figure 4. 3 The results of the affect of Ergo in NLF 10/1. A: absorbance in blue, B:
fluorescence in red, and C: sandwich ELISA in green demonstrated the nitration
chemical properties with respect Ergo effects. The circle presented NLF’s (TNM)
samples and the triangle presented NLF’s ONOO- samples.
4.4.3 Nitrated cornea tissue proteins used to investigate Ergo inhibitory property
The goal of this part of the work is to investigate the changes associated with
certain proteins due to nitration on an organ level. The inhibitory effects of Ergo will help
us to understand the nitration of these proteins en route to understanding their potential
importance in eye diseases and possibly toward finding a therapeutic target. Here, the
cornea tissue was tested since it has been shown that LF presence in mammalian cornea
and protein effects (Rageh, et al. 2016). The cornea lysate sample contains mixtures of
proteins including lactoferrin and the nitration will produce multiple protein nitrations.
The Ergo concentration (5.0 mM) was higher than NBSA and NLF experiments
to extend the highest level of protection, since the cornea lysate has many different
proteins and the nitration formation level was unknown. The absorbance data (Figure 4.
4. A) showed decrease in intensity due to the reduction of nitration formation by Ergo,
and the fluorescence data (Figure 4. 4. B) showed the increase in intensity via retraining
the fluorescence chemical properties via Ergo. The direct ELISA (Figure 4. 4. C)
quantified lower NTyr level in nitrated lysate with Ergo samples than nitrated lysate. The
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inhibitory effects of Ergo in lysate samples were matched to the above results for NBSA
and NLF which confirmed the anti-peroxynitrite activity of Ergo. This investigation
verified the robust ability of Ergo effects to protect proteins from the nitration process.

Figure 4. 4 The results of the affect of Ergo in N-lysate. A: Absorbance spectra in blue
mark, B: fluorescence spectra in red mark, and C: direct ELISA spectra in green mark.
4.4.4 The antibacterial activity retrained for NLF after the addition of Ergo
LF plays an important role in the antimicrobial function via several mechanisms.
In this study, the bacteria growth was monitored using visible absorbance at 600 nm. The
protein nitration using ONOO- was tested for lactoferrin since it is related to the
physiological nitration process and because Ergo has anti-peroxynitrite activity
(Franzoni, et al. 2006b). The protein nitration using TNM was not suitable for
antibacterial assay due to its toxicity. The antibacterial assay was tested for controls
which are LF, Ergo 5.0 and 50.0 mM as result showed in Figure 4. 5. Also, Ergo results
(Figure 4. 6. A and B) represented two different inhibitory models for Ergo to lactoferrin
nitration.
First, (Figure 4. 6. A) showed the effects Ergo in different concentration to one
molar ratio of nitrated lactoferrin. E.coli was tested against in several samples and
showed no growth for the blank and CAM antibiotic, highest inhibition for LF (22%),
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lower inhibition for NLF10/1 (12%) than NLF10/1-ERG 0.2 mM (-9 %), 1.0 mM (-2%),
5.0 mM (25%) and 10.0 mM (34%). The two concentrations NLF10/1-ERG 0.2 mM and
1.0 mM have a technical error and that explained the negative values. The E.coli linearly
inhibited with the increase of Ergo concentration in nitrated lactoferrin samples which
indicate antibacterial activity was protected during nitration by Ergo. P-values of E. coli
against all samples were < 0.001 significantly different except NLF10/1-ERG 1.0 mM <
0.1 due to a technical error.
Second, (Figure 4. 6. B) showed the effects nitrated lactoferrin in different
nitration molar to one concentration of Ergo 5.0 mM. E.coli was tested against many
samples; LF (23%) highest growth, higher inhibition in NLF10/1-Ergo 5.0 mM (45%),
NLF 20/1-Ergo 5.0 mM (32%), NLF30/1-Ergo 5.0 mM (21%) and NLF40/1-Ergo 5.0
mM (22%). P-values of E. coli against all samples were <0.001 significantly different.
The Ergo 5 mM concentration in NLF10/1 inhibit the nitration and bacterial growth
greater than the higher nitration molar NLF40/1. The presence of same Ergo
concentration (5 mM) with a different NLF molar ratio showed a competitive reactivity
of Ergo in protecting the protein from nitration, but generally, showed nitration
inhibition. This confirmed the importance of the dose response of Ergo with respect to
the level of protein nitration.
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Figure 4. 5 Antibacterial activity of controls Ergo 5.0 mM has antibacterial activity
similar to LF and Ergo 50.0 mM has the most antibacterial effect.
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Figure 4. 6 .Broth microplate antibacterial assay. Blank (broth, no E. coli), CAM
(positive control, strong inhibition), E. coli (negative control, no inhibition) tested
against A: LF and NLF at four molar concentrations 10/1, 20/1, 30/1, and 40/1 with
same Ergo concentration 5.0 mM, and P-values of E. coli against LF (0.0001), NLF10/1Ergo 5.0 mM (0.0001), NLF20/1-Ergo 5.0 mM (0.0001), NLF30/1-Ergo 5.0 mM
(0.0008), and NLF40/1-Ergo 5.0 mM (0.0005). B: LF and NLF10/1 with four Ergo
concentrations: 0.2, 1.0, 5.0, and 10.0 mM. Absorbance values shown without blank
subtraction. Bars show mean values ± standard deviations of n=4. P-values of E. coli
against LF (0.0001), NLF10/1 (0.0007), NLF10/1-Ergo 0.2 mM (0.0043), NLF10/1-Ergo
1.0 mM (0.81), NLF10/1-Ergo 5.0 mM (0.0047), and NLF10/1-Ergo 10.0 mM (0.031).
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4.5 Conclusion
The present work showed initial results regarding the inhibitory effect of Ergo in
the nitration reaction for several physiological proteins. Our observation of qualitative
and quantitative analysis showed an inhibitory effect of nitration through the addition of
Ergo. Specifically, BSA protein nitration with Ergo was significant dropping at NBSAErgo 1.0 mM comparing by NBSA. Also, LF protein nitration with Ergo and cornea
lysate nitration with Ergo showed decrease in nitration in the two nitration models
ONOO and TNM with slight different in inhibition due to the mechanism of producing
nitration from each model. Finally, the antibacterial activity results of Ergo-NLF showed
an increase of antibacterial activity than NLF.
The results suggest a correlation between the decreases of the protein nitration
level with the increase of Ergo concentration. This study demonstrated preliminary
results for Ergo nitration inhibition in several nitrated proteins using quantitative and
qualitative techniques, which could contribute to the potential treatment development for
nitrosative and oxidative stress linked diseases.
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Chapter five: Conclusion and future work
Protein nitration is a type of chemical modification that introduces nitro group
into amino acid residues. The body can be exposed to nitration through various vectors,
including via disease and air pollution. Certain proteins are highly affected by this
nitration process, including lactoferrin. LF is widespread within bodily fluid and plays a
role in health due to multitude of functions. Also, lactoferrin is used as a biomarker
protein for several diseases. There is also a relationship between decreases in lactoferrin
levels with many disease types, such as ocular disease.
The incidence of ocular surface disease are actively increasing as air pollution
continues to rise. Clinical examinations of the ocular surface have shown links between
reactive nitrogen species in air pollution and disease incidence, but the exact mechanism
of this link is unknown. The studies presented here investigate lactoferrin nitration using
a series of biochemical techniques. The observed chemical effect nitrogen species have
on lactoferrin was then applied to biological samples with the intent of finding a
therapeutic approach to preventing ocular disease caused by nitration.
Nitrotyrosine and lactoferrin, in tears, are both important biomarker targets for
ocular disease. Biochemical studies on detecting the effect of nitration with respect to the
decrease of lactoferrin in ocular disease are not well understood, so a method was
developed which allows for simultaneous detection of both markers in a single assay.
Fluorescence and absorbance spectrometric techniques were utilized to identify that
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standards of lactoferrin, with different nitration molar ratios, reveal a linear dependence
of binding between lactoferrin and nitrogen species. A unique, selective, and sensitive
sandwich ELISA detection technique utilizing two antibodies, anti-lactoferrin and antinitrotyrosine was then developed to quantify the amounts of nitrotyrosine in nitrated
lactoferrin samples. The sandwich ELISA method detecting nitrotyrosine bound to
lactoferrin is important in better understanding the biological role of the decreasing
lactoferrin levels in ocular disease.
Since lactoferrin is a host defense protein that protects the ocular surface, it’s
given that a loss of lactoferrin function is one potential link to ocular disease.
Considering the knowledge that nitration is linked to other air pollution disease this study
investigates potential effects that nitration of lactoferrin may have on its bioactivity. A
broth antibacterial assay shows lactoferrin’s antibacterial activity is diminished by
nitration in a concentration dependent manner. This effect was explained using circular
dichroism, in which spectra show conformational changes on lactoferrin due to nitration.
These observations help elucidate the mechanism of how ocular disease can be linked to
components of air pollution.
Given the negative effects nitration has on lactoferrin function a method of
inhibiting this nitration has high therapeutic potential in ocular disease. Ergothioneine, a
natural histidine mimic, is currently used as an anti-inflammatory, anti-oxidant, and antiperoxynitrite agent. Because it is already utilized in other areas, ergothionene was chosen
to pursue it as a target molecule to protect lactoferrin from nitration. To test its protection
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potential, we utilized previously discussed spectroscopic, antibacterial and ELISA
techniques, and our results universally show that ergothioneine blocks nitration of
lactoferrin. These finding show excellent potential in utilizing ergothioneine to maintain
health of ocular surface.
To better understand lactoferrin nitration within biological samples, I plan to
utilize a quantitative sandwich ELISA technique on tear samples from patients with
ocular surface disease. While tear analysis is one good way of investigating the effects of
lactoferrin nitration in biological samples, more research is needed on lactoferrin nitration
in living cells to evaluate whether they might exhibit altered function in vivo. To establish
this, further research for the nitration reactions need to be explored for toxic effects with
in vivo studies. Also, the quantification assay (ELISA) needs to be adjusted to the
concentration range to quantify nitrotyrosine based on the matrix sample.
We gained insight on the mechanism of this altered function by observing the
reduction in the antibacterial activity of nitrated lactoferrin, but future molecular structure
investigations will lead to more understanding in the antibacterial mechanism. Also, the
degree of nitration and the location of nitrotyrosine on lactoferrin will support the
investigation of antibacterial mechanism.
Finally, ergothioneine is an excellent target molecule for inhibit protein nitration
and help to maintain protein function, thus making it a robust treatment option with broad
applications in ocular therapy. This project needs further investigation in vivo, in addition
to concentration tests. The groundbreaking research detailed in this work may help in
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experimental designs, clinical examination, and the therapeutic improvements intended to
evaluate the role of protein nitration in ocular disease.
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Appendix A: Supplementary material for chapter two
A.1 Materials and reagents
Human milk lactoferrin (LF; L0520), bovine serum albumin (BSA; A7030),
tetranitromethane (TNM; T25003), Tween®20 buffer (P1379), Trizma base (TrisHCl; T1503), sulfuric acid (H2SO4; 320501), sodium phosphate dibasic
(RES20908-A702X), potassium chloride (P9333), sodium chloride (S9625),
potassium phosphate monobasic (P5655), sodium carbonate (S7795), sodium
bicarbonate (S5761), and ethanol (245119) were obtained from Sigma Aldrich
(USA). Sodium peroxynitrite (NaONOO; 516620) and Amicon Ultra centrifugal
filters (30 kDa, 4 mL size; UFC803024) were purchased from Calbiochem (USA).
The 1-step ultra 3,3’,5,5’-tetramethylbenzidine substrate (TMB; 34028) and
bicinchoninic acid assay (BCA; 23225) for total protein quantification were
purchased from ThermoFisher Scientific (USA). Flat-bottom, 96-microwell plates
(untreated; 333-8013-01F) and sterile sealing tape (ST-3095) were obtained from
Life Science Products (USA). A biotinylated, mouse monoclonal to nitrotyrosine
antibody (anti-NTyr; ab24496, clone number CC22.8C7.3), streptavidin
horseradish peroxidase (HRP; ab7403), and non-conjugated goat polyclonal antihuman lactoferrin antibody (anti-LF; ab77548) were obtained from Abcam (UK).
1.0 mL quartz cuvette with 10 mm path length (MF-W-10-LID) was purchased
from Science Outlet (USA).
Buffers used were: phosphate-buffered saline (PBS; 8.1 mM sodium phosphate
dibasic, 0.8 mM sodium phosphate monobasic, 1.3 mM potassium chloride, and
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68.0 mM sodium chloride at pH 7.4), Tris-HCl buffer (Tris; 0.1 mM at pH 8.0),
and carbonate buffer (29.0 mM sodium carbonate, 71.0 mM sodium bicarbonate at
pH 9.6).
The volumes of peroxynitrite used for production of NLFONOO- samples
discussed in Section A. 2. 1 were 5.66, 11.36, 17.05, 22.73, 34.10, 45.46, and
56.67 µL. Similarly, the volumes of TNM used for production of
NLFTNM discussed in Section A. 2. 2 were 0.29, 0.58, 0.86, 1.16, 1.72, 2.32, and
2.89 µL. These values correspond to molar ratios of nitrating agent to tyrosine
(ONOO-/Tyr) or (TNM/Tyr) of 10/1, 20/1, 30/1, 40/1, 60/1, 80/1, and 100/1. The
volumes of TNM used for production of NBSA discussed in Section A. 2. 4 and
S.6.1 were 0.95 and 7.33 µL of 6/1 and 14/1.
A.2 Micropipette precision
The maximum precision reported for the variable volume, single channel
micropipettes used (VWR; USA) is ± 1.5-0.3% for the 2-20 µL pipette (89079964), ± 0.6-0.2% for the 20-200 µL pipette (89079-970), and ± 0.4-0.15% for the
100-1000 µL (89079-974). The 12-channel micropipette (4662030) has a
maximum precision of ± 2.0-0.3% for the 30-300 µL purchased from (Thermo
scientific, USA). The coefficient of variation for the small transfer pipette with
variable volume 0.1-2.5 µL (704769; Transferpette-S, USA) is 0.7%, and 0.5% for
the 0.5-10 µL volume pipette (704770).
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A.3 Purification of nitration reaction products
After nitration reactions were completed, selected samples were analysed
before and after purification. 1.0 mL of NLF was purified using an Amicon Ultra
centrifugal filter with a 30 kDa cut-off membrane and rinsed twice with 1.0 mL
PBS buffer. The total concentration of LF in each sample was determined using a
bicinchoninic acid assay, following kit instructions. The absorbance of each
solution was measured in triplicate, and the protein concentration of each solution
was determined by comparing against an eight point calibration curve generated
using BSA standard in a concentration range between 25 and 2000 µg mL-1.
A.4 Sandwich ELISA for optimization of polyclonal to lactoferrin antibody
For the sandwich ELISA procedure, goat polyclonal to lactoferrin nonconjugated antibody was used as the capture antibody and mouse monoclonal to
nitrotyrosine biotinylated antibody was used as the detector antibody. Capture
antibody was diluted in carbonate buffer in several dilution ratios (1:250, 1:500,
and 1:1000). Three microwells were coated with 50 µL of each capture antibody
dilution, and the plate was incubated at 4°C for 17 hours. The plate was washed
and blocked as described in Section A. 2. 6.
NLF (40/1 TNM/Tyr) was serially diluted into blocking buffer producing NLF
solutions at seven concentrations (0.19, 0.39, 0.78, 1.56, 3.12, 6.25, and 12.5 µg mL-1).
Thus, each of seven concentrations of NLF was aliquoted into 9 wells (three capture
antibody dilution ratios X triplicate measurements) for ELISA treatment. After
incubation and washing, 50 µL of each NLF solution was added in triplicate to
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wells processed with capture antibody in each of the three dilution ratios and
incubated for 2 hour at RT. Blocking buffer was added separately to three wells as
a blank measurement. After washing, 50 µL the detector antibody, diluted 1:100 in
blocking buffer, was added to each well and incubated for at room temperature for
1 hour. The assay was analysed spectroscopically using the procedure detailed in
Section A. 2. 6.
The polyclonal anti-LF capture antibody recognizes a specific peptide
sequence (432-444: C-ENYKSQQSSDPDP) in the LF protein. The amino acid
nomenclature used here: E (glutamic acid), N (asparagine), Y (tyrosine), K
(lysine), S (serine), Q (glutamine), D (aspartic acid), P (proline).
A.5 Purification is not required before quantification
NLF produced using TNM also contains nitroformate as by-product, which
has the same absorbance wavelength as NTyr (350 nm), which adds ambiguity to
the interpretation of the NTyr spectral results. Figure A. 7 shows UV-vis
absorbance and sandwich ELISA results for both purified and non-purified
reaction products. Products before and after purification show similar trends. The
absorbance intensity was slightly reduced after purification due to removing
nitroformate by-product, but the sandwich ELISA result remain the same. We
conclude that the purification process is not required for the sandwich ELISA
process to achieve quantitative results.
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A.6 Development and optimization of antibody usage
A.6.1 Anti-NTyr detector antibodies (polyclonal or monoclonal)
The initial step in the development of the NLF sandwich ELISA was to
choose the anti-NTyr detector antibodies. We used direct ELISA to test nitrated
bovine serum albumin (NBSA) using two different biotinylated nitrotyrosine
antibodies: mouse monoclonal nitrotyrosine (ab24496) and goat polyclonal
nitrotyrosine (ab27646). The monoclonal anti-NTyr antibody has increased
specificity to binding at a specific epitope, compared to the polyclonal antibody
that allows binding at multiple epitope, and thus allows sensitive quantification of
antigens that contain the monoclonal epitope. NBSA was nitrated using two
concentrations of excess nitrating agent (molar ratio of excess TNM to tyrosine of
6/1 and 14/1). The monoclonal anti-NTyr exhibited higher sensitivity than the
polyclonal anti-NTyr to detect NBSA produced at both TNM concentrations, as
shown in Figure A. 1.
A.6.2 Anti-LF capture antibody
The polyclonal antibody (ab77548) considered here for the capture portion of the
assay contains a peptide sequence that includes only one tyrosine residue, which is
included in the iron-binding site (Steijns, et al. 2000). Teuwissen et al. reported that iron
binding of LF was not reduced after nitration, which suggests that the tyrosine residues
involved in the iron binding region will not be nitrated and, by extension, will not affect
the binding to this specific antibody (Teuwissen, et al. 1973). The antibody under
consideration had previously shown a successful binding response for human samples
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in immunoassays such as western blot, in human peripheral mononucleocytes, and
using immunohistochemical assays for human tissues (Fahrbach, et al. 2013; de la
Rosa, et al. 2008). Additionally, this capture antibody matches as a pair antibody to the
anti-NTyr detector antibody previously chosen (Section A. 6. 1). Based on these piece of
literature support, we tested the capture antibody via the ELISA. The results confirmed
detection of NLF, supporting the assumptions stated above. A.6.3 Antibody sequence for
the sandwich ELISA
The polyclonal anti-LF contains a pool of immunogenic antibodies for the
specific peptide sequence listed above (Section A. 4). This allows the anti-LF antibody to
recognize the specific peptide epitope in multiple arrangements, thus increasing the
probability that binding occurs between anti-LF and LF.
Following the testing of the individual antibodies, the amplification of antiLF was tested for use in the sandwich ELISA using combinations of four
antibodies: [a] goat polyclonal capture anti-LF (ab77548), [b] rabbit polyclonal
detector anti-LF (ab25811), [c] rabbit polyclonal capture anti-NTyr (ab42789), and
[d] mouse monoclonal detector anti-Ntyr (ab24496). The following antibody
combinations were tested:
(1) capture anti-LF [a] and detector anti-LF [b]
(2) capture anti-NTyr [c] and detector anti-NTyr [d]
(3) capture anti-LF [a] and detector anti-NTyr [d]
Combination 1 (Fig. A. 2, red bars) show detection of LF, as expected because of
the two anti-LF antibodies, but very little in the NLF case. Combination 2 (brown
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bars) shows detection of NLF, which is expected because the antigen was nitrated
using excess nitrating agent. This combination did not show detectable signal with
pure LF, which is expected given that the capture antibody is specific for NTyr.
Combination 3 (blue bars) shows detection of NLF, but very little in the LF case.
All three combinations show very little detection of the blank (blocking buffer
incubated under otherwise identical conditions). Combinations 1 and 3 both utilize
the same capture antibody (anti-LF). The fact that combination 3 shows efficient
detection of NLF, but combination 1 does not, suggests that the capture binding of
antigen to antibody is not inhibited by antigen nitration. This may imply that the
detector antibody binding is inhibited by nitration. The anti-LF capture antibody
binds whether LF is the antigen (red bars, center) or NLF is the antigen (blue bars,
right). The anti-LF detector also to LF (red, center), but not to NLF (red, right).
We conclude from this study that using the anti-LF as capture antibody presented
minimal reduction in binding sensitivity and that Combination 3 was viable for
further testing (see manuscript for subsequent details).
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A.7 Supplemental Table and Figures
Table A.1 Statistical tests comparing detection of NLF vs. LF. NLF concentration
at each point from manuscript Figure A. 4 (dark yellow points) compared against
LF mean (red line, 0.0187 ± 0.005 AU).
NLF concentration
µg mL-1

p-value

t-value

0

0.26

1.15

0.1875

0.0001

11.7

0.375

0.0001

15.7

0.75

0.0001

28.8

1.5

0.0001

57.1

3

0.0001

76.6

6

0.0001

105

12

0.0001

215

25

0.0001

106
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Figure A. 1 Absorbance results from indirect ELISA using NBSA antigen nitrated at
two ratios of TNM to tyrosine (6/1 and 14/1). Marker color indicates NTyr antibody used
for detection NBSA antigen diluted into blocking buffer. The green marks represented
mouse monoclonal nitrotyrosine (ab24496) and the red marks represented goat
polyclonal nitrotyrosine (ab27646).Data points are mean values, with error bars
as standard deviation of absorbance measurements from individual wells (n = 2).
In some case the uncertainty is smaller than the marker point and is not visible.
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Figure A. 2 Absorbance results from sandwich ELISA testing efficacy of chosen
antibodies: anti-LF capture (ab77548), anti-NTyr capture (ab42789, anti-LF
detector (ab25811), and anti-NTyr detector (ab24496). Antigen selection shown on
x-axis legend: Blank (PBS-1buffer), LF, and NLF (40/1 TNM/tyrosine). Each
antigen used at 0.5 µg mL . Order of antibody placement in ELISA indicated in
legend. Bars are average values, with error bars as standard deviation of
absorbance measurements from individual wells (n = 2).
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Figure A. 3 Conceptual model for the antibodies sequence of NLF sandwich ELISA.
Shown from bottom to top: non-conjugated anti-lactoferrin (anti-LF) as capture
antibody (randomly oriented), NLF as antigen, biotinylated anti-nitrotyrosine
(anti-NTyr) as a detector antibody, and streptavidin conjugated to HRP. Figure
adapted from de la Rica and Stevens (De La Rica, et al. 2012).
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Figure A. 4 Dilution ratio plot for anti-lactoferrin and shows ELISA well absorbance at
four dilution factors (anti-LF into blocking buffer). Data points are mean values ±
s, n= 3. Traces are linear fits.
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Figure A. 5 Sandwich ELISA of NLFTNM (a) and NLFONOO- (b). Error bars show
standard deviation of absorbance measurements from individual wells.
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Figure A. 6 The absorbance of NLFTNM (a) and NLFONOO- (b). Legend value
shows molar ratio of nitrating agent (TNM or ONOO-) to tyrosine.
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Figure A. 7 The absorbance of non-purified NLFTNM (a-b: top panels) vs. purified
NLFTNM (c-d: bottom panels). Legend value on panels in left column (UV-vis results)
shows molar ratio of TNM to tyrosine.
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Appendix B: Extraction and quantification of LF from animal cornea
The following appendix includes preliminary research results toward quantify LF
from animal tissue. A summary of the results and analysis are obtainable here as a
documentation of my research in animal tissue which will help with future research.
B.1 Overview
Our project is investigating the effect of the nitration process that plays a role in
diseases such as ocular disease. We will begin this study by performing in-vitro
experiments on corneal lamb tissue which will help us investigate changes in the eye
without requiring in-vivo experimentation.
The first experimental group will be the control group from which we will extract
specific proteins (i.e. lactoferrin). To the second experimental group we will apply
liquid-phase nitration reactions and extract the proteins to measure the extent of the
nitration on the proteins. See chapter 3.
The goal of this project is to investigate the proteins changing due to nitration
reaction on the cell level which will help us to understand the nitration of these proteins
en route to understanding their potential importance in ocular diseases.
B.2 Materials and methods
Bovine cornea (age: 12-30 months, mixed gender) and rat cornea (age: 7-8 weeks,
mixed gender) purchased from Pel-Freez Biological (AR, USA). Lamb cornea (age: 3
months, male gender) donated from local butcher store (Jerusalem Market, E. Illif Ave.),
FDA approved for human consumption and handling. 4-(2-Hydroxyethyl) piperazine-1110

ethanesulfonic acid, N-(2-Hydroxyethyl)piperazine-N′-(2-ethanesulfonic acid) (HEPES;
H3375), bicinchoninic acid Assay (BCA), Triton X-100 (X100),
ethylenediaminetetraacetic acid anhydrous, bioultra (EDTA) , and sodium chloride
(S9625) were purchased from sigma-aldrish (USA). HALT (tm) protease inhibitor (PI;
QB203967A) from fisher scientific company (PA, USA).
Nitration reactions tetranitromethane (TNM), Sodium peroxynitrite (ONOO-), Amicon
Ultracentrifuges tube cutoff 30K, Carry Bio 100 UV-vis spectrometer, and Carry eclipse
Fluorescence spectrometer .
The buffers used are: extraction buffer (EB) solution (50.0 mM Tris-HCl, 10.0
mM HEPES, 150.0 mM NaCL, 5.0 mM EDTA, 0.5 % Triton at pH 7.7, and then fresh
add 10 % PI) and Tris-HCl buffer (Tris; 50 mM at pH 8.0).
Human milk lactoferrin (LF; L0520), bovine serum albumin (BSA; A7030),
tetranitromethane (TNM; T25003), Tween®20 buffer (P1379), Trizma base (TrisHCl; T1503), sulfuric acid (H2SO4; 320501), sodium phosphate dibasic
(RES20908-A702X), potassium chloride (P9333), sodium chloride (S9625),
potassium phosphate monobasic (P5655), sodium carbonate (S7795), sodium
bicarbonate (S5761), Ammonium persulfate (APS; A3678), glycine (G8898),
glycerol (G5516), acetic acid (320099), methanol (34860), Sodium dodecyl sulfate
(SDS; L3771), and ethanol (245119) were obtained from Sigma Aldrich (USA).
Sodium peroxynitrite (NaONOO; 516620), Amicon Ultra-0.5 centrifugal filters
(30 kDa, 0.5 mL size; UFC503008), and Amicon Ultra centrifugal filters (30 kDa,
4 mL size; UFC803024) were purchased from Calbiochem (USA). The 1-step ultra
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3,3’,5,5’-tetramethylbenzidine substrate (TMB; 34028) and bicinchoninic acid
assay (BCA; 23225) for total protein quantification were purchased from
ThermoFisher Scientific (USA). Flat-bottom, 96-microwell plates (untreated; 3338013-01F) and sterile sealing tape (ST-3095) were obtained from Life Science
Products (USA). A biotinylated, mouse monoclonal to nitrotyrosine antibody (αNTyr; ab24496), streptavidin horseradish peroxidase (HRP; ab7403), and nonconjugated goat polyclonal anti-human lactoferrin antibody (α-LF; ab77548) were
obtained from Abcam (UK). 1.0 mL quartz cuvette with 10 mm path length (MFW-10-LID) was purchased from Science Outlet (USA).
Iron(III) chloride hexahydrate (FeCl3.6H2O; 236489), Nitrilotriacetic acid (NTA;
N9877), Trizma base (Tris-HCl; T1503), Hydrochloric acid (H-7020), Tryptic Soya broth
(TSB; 22092), and Tryptic Soya agar (TSA; 22091) were obtained from Sigma Aldrich
(USA). 100mmx15mm petri dish with grip ring, sterile (229692) providate from
CELLTREAT (USA). Uv 96-microwell plates with transparent flat bottom (3635) was
purshaced from CORNING (USA). Escherichia coli (E. coli; ATCC25922) was
purchased from the American Type Culture Collection, ATCC (USA). Precision-plus
protein dual color standard (ladder; 1610374), 30% acrylamdie 29:1 (1610156),
Tetramethylethylenediamine (TEMED; 1610800), Precision Plus Dual Color
Standards (1610374), and Coomassie blue R250 (1610436) BIO-RAD (USA).
Buffers used were: phosphate-buffered saline (PBS; 8.1 mM sodium phosphate dibasic,
0.8 mM sodium phosphate monobasic, 1.3 mM potassium chloride, and 68.0 mM sodium
chloride at pH 7.4), Tris-HCl buffer (Tris; 0.1 mM at pH 8.0), carbonate buffer (29.0 mM
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sodium carbonate and 71.0 mM sodium bicarbonate at pH 9.6), loading buffer ( 200 mM
tris-HCl pH 6.8, 400 mM dithiothreitol (DTT), 0.4% bromophenol blue, 40% glycerol
and 8% SDS), running buffer (25 mM Tris-HCl, 192 mM glycine, and 0.1 % SDS), gel
staining (coomassie blue R250 1%, acetic acid 10%, methanol 50%, and 40% water), gel
destine buffer (50% methanol, 10% acetic acid, and 40% water), and Ferric
nitrilotriacetate (Fe(NTA)2) solution (FeCl3.6H2O 4.0 mM and NTA 8.0 mM and 1 N
HCl add 2% to total solution volume at pH 4.0), and the tryptic soya broth, and
tryptic Soya agar was prepared following the manufacture instructions. SDSPAGE gel containing 3.2 % stacking gel (30% Acrylamide 266.7 µL, Tris-HCL
(1.5M) 312.5 µL, 10% SDS 25 µL, water 890.8 µL, APS 50 µL, and TEMED5
µL) and 10 % running buffer (30% Acrylamide 4166.7 µL, Tris-HCL (1M) 3125.0
µL, 10% SDS 125 µL, water 5070.8 µL, APS 125 µL, TEMED 12.5 µL).
B.3 Dissection of the cornea
B.3.1 Lamb cornea
The steps for lamb eye dissection to separate the cornea are as follows:
a. Washed the eye from the blood using water, washed first and Tris-HCl second
and dried using the paper towel, see Figure B. 1.
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Figure B. 1 The whole lamb eye after washed and dried.
b. The fatty tissue and muscles around the eye were removed using surgical scissors,
see Figure B. 2.

Figure B. 2 Removing the fatty tissue and muscle around lamb eye.
c. The eye was silted using a surgical razor blade and then the point of the scissors
was inserted into the slit and cut the eye sclera all the way around to get the eye
into two halves. Each half of the eye was washed with Tris-HCl to remove the
vitreous humor liquid that released after cutting the eye. The eye lens and iris
were removed by the surgical forceps, see Figure B. 3.
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Figure B. 3 The lens (1) and iris with pupil (2) were separated from the front side of the
lamb eye.
d. After detaching the lens and iris, the cornea was cut from the eye hemisphere
using scalpel. The eye section and the tools used are shown in Figure B. 4 below.

Figure B. 4 The sections of the eye after dissection are; cornea (1), lens (2), iris (3),
connective tissue around the cornea (4), half of the back side of the eye with the optic
nerve, fatty tissue, and muscle around the eye (6), and the tools were used in the right
side.
e. The lamb corneas were cut into four pieces and weighed, then snap frozen the
tissue and stored it at -20 ºC until lysate extraction process.
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B.4 Bovine and rat corneas
The bovine and rat corneas were purchased, as previously separated from the
vendor and cut into four pieces using razor blade and weighed. Then snap frozen the
tissue and stored at -20 ºC until lysate extraction process.
B.5 Tissue lysate from lamb, bovine, and rat
The cornea tissue was lysate using the follows protocol. The tissue was placed in
the microtube and EB 10 % of tissue mass was added. Next, it was rotated at the cold
room for 25 minutes and then sonicated at 8 powers for 2 minutes in ice. Finally, the
mixture was centrifuged at 1400 g for 30 minutes in the cold room. The supernate was
collected and aliquot in cryogenic microtube and store in -20 ºC until further analysis.
B.6 Qualitative analysis for tissue lysate using spectroscopy analysis
B.6.1 Quantification the total protein using BCA
The BCA used to quantify the total amount of the proteins from cornea lysate
following the manufacture instruction.
B.6.2 Determination of protein using UV-vis and EEM
Quartz cuvette was used for spectroscopy analysis. Carry BIO 300 spectroscopy
was used to detect the scan absorbance of protein at wavelength 230-500 nm. Carry
eclipse spectrophotometer was used to detect EEM at excitation wavelength 200-500 nm
and emission stop at 400 nm with 2 increments.
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B.7 Quantitative analysis for LF from tissue lysate
B.7.1 Sandwich ELISA
Sandwich ELISA was used to quantify LF protein using the following protocol:
The goat polyclonal to lactoferrin non-conjugated antibody (α-LF-n) was used as
the capture antibody, and rabbit polyclonal to lactoferrin biotinylated antibody (αLF-B) was used as the detector antibody. An optimal dilution ratio of 1:5000
capture antibody to carbonate buffer was followed from the abcam manufacturer
recommendation. Microwells were coated with 50 µL of the diluted capture
antibody and incubated at 4°C overnight. After incubation, the wells were washed by
adding 200 µL of PBST (PBS with 0.05% Tween) to each well and tapping the plate
upside down on a laboratory wipe to remove excess buffer, repeating twice. Each
subsequent incubation step also followed a similar process of sealing, followed by
continuous shaking during the incubation period using a rocking platform (UltraRocker,
BIO-RAD), and then duplicate washing with PBST. LF was serially diluted into
blocking buffer producing LF solutions at eight concentrations (0, 0.24, 0.48,
0.097, 1.95, and 3.90 ng mL-1). After a second washing step, 50 µL of each of the
five LF solutions were added in triplicate to the plate and incubated at room
temperature for 1 hour. Blocking buffer was used for blank measurements. 50 µL
of the detector antibody, diluted in blocking buffer to a ratio of 1:1000, was then
added, and the plate was incubated with shaking at room temperature for 1
hour. Streptavidin-HRP and TMB were added following the ELISA protocol, as
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described above. The standard calibration curve was made according to the
absorbance at each concentration of LF.
B.7.2 Sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) for
molecular weight determination
LF (1 mg/mL), bovine, lamb, and rat cornea lysate in PBS were heated at 90°C
for 8 min, containing loading buffer 1:1 dilution. The SDS-PAGE protocol followed by
U. K. Laemmli, the mini gel performed on discontinuous buffer gel of - 3.2% stacking 10% running polyacrylamide.(Laemmli 1970) The stacking 3.2% has large pore size
which will increase the protein resolution before separating it onto running gel. The
running gel 10% has good separation for the range of 80 kDa molecular weight protein.
B.8 Results and discussion
B.8.1 BCA assay
The cornea total proteins was detected and the result shows that the increased in
total protein direct proption with the increase of the size of the cornea as shows in Figure
B. 5, bovine cornea >lamb>rat.
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Figure B. 5 The BCA calibration curve (A) used to detect the total protein in animal
cornea (B).
B.8.2 UV-vis
The absorbance at 280 nm was detected in all cornea lysate and LF spectra used
for comparison. The absorbance intensity at 280 nm was increased with the increased in
animal cornea size as shows in (Fig. B. 6. B-D).
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Figure B. 6 The absorbance spectra of LF 1mg/mL used as control (A), rat absorbance is
10 times higher than LF (B), lamb absorbance is 20 times higher than LF (C), and bovine
absorbance is 30 times higher than LF (D).
B.8.3 EEM
The fluorescence spectra EEM used to detect multiple emission intensity for
multiple excitation wavelength. The EEM of LF used as positive control, rat lysate, lamb
lysate, and bovine lysate see (Fig. B.7. A-D).
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Figure B. 7 The EEM spectra of LF 1mg/mL (A), rat (B), lamb (C), and bovine (D).
B.8.4 SDS-PAGE
The routine SDS-PAGE protocol is a sensitive technique for the analysis of protein
components of a matrix and was used with gel stained by coomassie blue and silver stain.
The gel was scanned using an Epson scanner to provide the resultant image. Figure (B. 8.
A) shows an example result where rat LF has a band lower than the bovine and lamb LF
because of the low concentration. Also, we detected the relative intensity using imageJ
programe to quantify the gel bands (see Figure B. 8. B).
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A

B

Figure B. 8 (A) SDS-PAGE with Coomassie blue stain, (B) the relative intensity of gel
bands.
B.8.5 Sandwich LF ELISA
To detect LF concentration in animal cornea lysate, sandwich LF ELISA
was used. The Figure B. 9 shows that the LF increase with the increasing of the
cornea size.
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B

Figure B. 9 (A) Sandwich ELISA calibration curve of human milk LF, (B) the bar graph
for quantify cornea concentration.
B.9 Summary
Sandwich ELISA was used to quantify LF in animal cornea. The LF
concentration in animal cornea increased linear with the cornea size.
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Appendix C: Ergo experimental plan
The following Figure C. 1 represented Ergo research plan for protein nitration.

Protein Nitration Plan

TNM

- Vary
concentration
- Change
solution-phase
to (ONOO-)
- Gas-phase
nitration

BSA

- LF
- Extracted
proteins to:
* Animal cornea
* Human cornea

ERGO

- Vary
concentration

Figure C. 1 A diagram of Ergo research plan.
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Detection

- Sandwich ELISA
(3-Ntyr)
* Kit
* In-house
- Spectroscopy
* Uv-vis
* Fluor

Appendix D: Kirby Bauer assay
D.1 Materials
Glycerol stock of Escherichia coli (ATCC25922) or Streptococcus faecalis (ATCC
19433) was inculcated into 4 mL Tryptic Soya agar (TSA) (Sigma Aldrich 22091) and
incubated at 37ºC for 24 hrs. Then a few separate colonies 3-5 were selected and transferred
into Tryptic Soya broth (TSB) (Sigma Aldrich 22092) and incubated at 37ºC for 24 hrs.
Muller Hinton agar (MHA) (Sigma Aldrich M9552) was plated and storage in 4ºC until
use. The plate has to incubate at 37ºC for 30 min before the assay. Then, 3 µL of the bacteria
transferred directly into Muller Hinton agar plate and spread homogenously. The plate was
dried for 3-5 minutes before the disc add. Blank disc (Remoel CT0998B) was loaded with
20 µL of the sample and placed into MHA plate and gentle press was applied to the disc
before incubated at 37ºC for 24 hrs.
Test several growths Agar to improve the assay such as Tryptic Soya agar, Luria
Broth Agar, and Muller Hinton agar. Then, many broths were tested in bacteria growth
such as Tryptic Soya broth, Luria Broth, and Brain Heart broth. Test LF concentration 0.11 mg/mL in water and PBS.
Aim of Kirby Bauer (KB) study: To investigate antibacterial activity using zone of
inhibition see the following scheme.
Inhibition
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Zone of inhibition is the area around the disk that get affected by the antibiotic.
D.2 Methods
1 µL of glycerol stock aliquot of Escherichia coli (ATCC 25922) was inculcated
Tryptic Soya agar (TSA) (Sigma Aldrich 22091) plate and incubated at 37ºC for 24 hrs.
Then a few separate colonies 3-5 were selected and transferred into 4 mL Tryptic Soya
broth (TSB) (Sigma Aldrich 22092) and incubated at 37ºC for 24 hrs. After incubation
dilute this 4 mL into 50 mL TSB to make E.coli stock. The samples were placed into 96microwell plate and 200 1 µL per well was used. All samples was prepared in TBS, (Blank)
is TSB, (positive control) is chloramphenicol antibiotic in 60 µL mL-1, LF and NLF was
diluted it into 1mg mL-1. Then 5 µL of E. coli stock was added to each well and incubated
at 37ºC for overnight. Finally, microwell plate was detected by the plate reader (Tecan
Infinite, M1000 PRO) at wavelength 600 nm.
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D.3 Results
The agar plate showed the zone of inhibition of LF vs. NLF 10/1, NLF 20/1, NLF
30/1, NLF 40/1. The increase of nitration direct associated to the decrease of the zone of
the inhibition, see Figure D. 1.

Figure D. 1 Three agar plates showed the antibacterial affect using zone of inhibition for
LF vs. NLF 10/1, 20/1, 30/1, and 40/1.

Sample

10uL- E.coli

20uL- E.coli

5uL- E.coli

LF

Not clear

18 mm

17 mm

NLF 10/1

Not clear

15 mm

11 mm

NLF 20/1

Not clear

15 mm

10 mm

NLF 30/1

Not clear

14 mm

10 mm

NLF 40/1

Not clear

14 mm

8 mm
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Appendix E: Buffer pH changed the nitration product yield
This study helped us to test the effect of the buffer pH in nitration reaction using
TNM.
Figure E. 1 represents the absorbance spectra of BSA (TNM) nitration product
using several buffers with different pH. The nitration reaction product increase with the
increase of the buffer pH and the pH 12 buffer showed highest nitration peak at
wavelength 350 nm. Also, no shift was observed in the nitration product peaks see Figure
E. 1. Our concern was between Tris-HCl and PBS because they were the main buffers we
used in TNM nitration reaction and both have similar nitration products.

Figure E. 1 UV-Vis spectra of nitration reaction of BSA using TNM in several pH buffer
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Appendix F: Comparison study of nitration reaction of aromatic amino acids using
ONOO- and TNM

This study is a side project that helped to analyze the absorbance and EEM
spectra for nitrated protein.
The following four set of Figures F. 1-4 showed the affect of nitration agents in
free aromatic amino acid (Tryptophan, Tyrosine, Phenylalanine, and Histidine) and how
that changes the optical properties. Our results matched the previous study by Mayer et
al. for native amino acids for EEM analysis (Meyer, et al. 2015) and for absorbance from
(Saidel, et al. 1952).
F.1 Tryptophan (Trp) and nitrated tryptophan (NTrp)
Trp as a native form has the highest absorbance and fluorescence intensity among
aromatic amino acids. Figure F.1. A showed an absorbance band in 280 nm for Trp and
two bands after nitration at 280 and 350 nm. Figure F.1 Figure F.1. B showed
fluorescence intensity between 300-450 nm for Trp and it is reduced after nitration.
The nitration agents TNM and ONOO- have different amino acids mechanism in
nitration but they all share producing nitrotyrosine. The TNM agent nitrated aromatic
amino acids but produced mostly nitrotyrosine which explain the more reduction in EEM
intensity than ONOO-. Also, ONOO- has oxidation affect to cystine and methionine
beside the nitration of Tryptophan, Tyrosine, Phenylalanine, and Histidine.
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A

B

Figure F. 1 (A) Absorbance spectra for (B)EEM spectra for Tyr before (top) and after
nitration (bottom).
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F.2 Tyrosine (Tyr) and nitrated tyrosine (NTyr)
Tyr as a native form has the second highest absorbance and fluorescence
intensity among aromatic amino acids. Figure F. 2. A showed absorbance band in 270
nm for Trp and two bands after nitration at 270 and 350 nm. Figure F. 2. B showed
higher fluorescence intensity between 280-350 nm for Tyr and it is reduced after
nitration. As mentioned above the nitration agents TNM and ONOO- have different
amino acids mechanism in nitration, but they all share producing nitrotyrosine. The TNM
agent produced mainly nitrotyrosine and nitrotryptophan which explain the greater
reduction in EEM intensity than ONOO-. Here ONOO- reduced the fluorescence intensity
between 280-350 nm and generated a strong intensity between 380-500nm which related
to dityrosine as a product of ONOO-.(Goldstein, et al. 2008) Also, the fluorescence range
matched to Al-Garawi et al fluorescence study for dityrosine.(Al-Garawi, et al. 2017).
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B

Figure F. 2 (A) Absorbance spectra and (B)EEM spectra for Trp before (top) and after
nitration (bottom).
133

F.3 Phenylalanine (Phe) and nitrated Phenylalanine (NPhe)
Phe as a native form has the lowest absorbance and fluorescence intensity among
aromatic amino acids. Figure F. 3. A showed absorbance band at 260 nm for Phe and
two bands after nitration at 260 and 350 nm. Figure F. 1. B showed low fluorescence
intensity between 280-300 nm and it is reduced after nitration. The nitration products
have similar reduction after nitration as NTrp.
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B

Figure F. 3 (A) Absorbance spectra and (B)EEM spectra for Phe before (top) and after
nitration (bottom).
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F.4 Histidine (His) and nitrated Histidine (NHis)
Figure F. 4. A showed His nitration band at 350 with ONOO- and no absorbance
band with TNM. Figure F. 4. B His as a native form does not have fluorescence intensity
and that matched to previous EEM study (Meyer, et al. 2015) which make it hard to
detect the nitration fluorescence with ONOO- .
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B

Figure F. 4 (A) Absorbance spectra and (B)EEM spectra for His before (top) and after
nitration (bottom).
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Appendix G: Infrared spectroscopic analysis for test functional groups of lactoferrin
nitration
The following IR spectra used to investigate the fictional group of lactoferrin and
nitrated lactoferrin.

Figure G. 1 IR spectra LF vs. NLF10/1, and NLF10/1-Ergo 1.0 mM.
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Figure G. 2 IR spectra LF-Fe vs. NLF10/1-Fe, and NLF10/1-Ergo 1.0 mM-Fe.
Figures G. 1 and 2 showed the functional groups that shows in the IR spectra for
lactoferrin nitration samples 5mg/mL concentrations with and without Fe+3. The spectra
bands described as: amid I band 1700-1600 cm-1, amid III band 1229-1301 cm-1 for CN
stretching and NH bonding, amid B band 3300 cm-1 for NH stretching, amid B band 3300
cm-1. The Tyr-OH band is in 1614-1621 cm-1 which showed decrease after nitration.
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Appendix H: Iron binding analysis
H.1 Method: Iron titration to detect iron-binding capacity
The iron-binding assay was prepared following procedures outlined by Hamilton
et al. (Hamilton, et al. 2009). After nitration reaction samples were purified, each
UV-microwell was coated with 200 µL of either LF, NLF 10/1 NLF 40/1, NLF10/1Ergo 0 .1, and NLF10/1- Ergo, 0.5 mM.. To each well, 1 equivalent of Fe(NTA)2 was
added, and the absorbance was measured using the plate reader after five minutes of
waiting at room temperature. Another equivalent of iron was then added and the process
was repeated until a total of nine equivalents had been analyzed. The absorbance of each
well was detected using the plate reader at wavelength 470 nm.
H.2 Result: Iron-binding strength of LF and NLF
To determine the strength of the binding affinity from both unmodified and
nitrated LF to Fe3+, equivalents of Fe(NTA)2 were titrated into solutions of LF, NLF 10/1
NLF 40/1, NLF10/1, NLF10/1- Ergo 0 .1,and NLF10/1- Ergo, 0.5 mM. Absorbance of
the resultant solutions were measured at 470 nm (Fig. H. 2), where increasing absorbance
indicates additional iron bound within the protein after addition to the ferric ion (Fe3+),
according to Figure H. 1.
3+

Fe

+

LF

3+

Fe - LF

Figure H. 1: Addition of ferric ion to lactoferrin.

140

+ 2H+

Figure H. 2 Identified iron binding activity of absorbance spectra of iron titration for LF,
10/1 NLF, an 40/1 NLF in spectra (A), , NLF10/1, NLF10/1- Ergo 0 .1,and NLF10/1Ergo, 0.5 mM.in spectra (B), data points are mean values ± , (spectra A:n= 5 and spectra
B:n=1).
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The absorbance of iron binding represented in (Figure H. 2, graph A). The binding
strength was tested for each sample using absorbance at wavelength 470 nm. There were
no significant differences in iron binding for LF comparing to NLF 10/1 and 40/1. Same
results for Ergo, there were no significant differences between NLF10/1, NLF10/1-0
Ergo.1, 0.5 mM and LF in (Figure H. 2, graph B). This finding suggested that the LF
binding site was not affected by nitration.
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Appendix I: Denaturing study of LF and NLF 40/1-(TNM) using guanidine in four
different concentrations 0.25, 0.5, 1.0, and 2.0 M
The guanidine used to test the denaturing difference between LF and NLF 40/1.
The denature effect of guanidine was examined using two techniques: EEM and SDSPAGE.
I.1 SDS-PAGE
The SDS-PAGE (Figure I. 1) showed one strong band for LF-Guanidine 0.25, 0.5,
1.0, and 2.0 M at molecular weight 75kDa. There were two strong bands for NLF 40/1Guanidine 0.25, 0.5, 1.0, and 2.0 M around 75 kDa and one at 50 kD. There is missing
band for LF 0.5 guanidine due to technical error.
These bands indicate the structure change of NLF 40/1 from LF due to the
different response with the denature agents.

Figure I. 1 The SDS-PAGE stained with silver nitrate. The bands were presented ladder,
LF-Guanidine 0.25, 0.5, 1.0, and 2.0 M , and NLF 40/1 Guanidine 0.25, 0.5, 1.0, and 2.0
M.
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I.2 EEM
The guanidine fluorescence was tested as background for the detection and does
not show fluorescence properties (Figure I. 2).

Figure I. 2 The EEM of guanidine 2.0 M.
The EEM for LF at wavelength range 300-350 nm showed decrease in
fluorescence intensity with the increase of guanidine concentrations (Figure I.3)
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Figure I. 3 The EEM of LF and guanidine in four concentrations.
The EEM for NLF 40/1 at wavelength range 300-350 nm decrease as the
guanidine concentration increase (Figure I. 4).
The behavior of LF comparing to LF 40/1 were different which indicate structure
dysfunction of LF after nitration.
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Figure I. 4 The EEM of NLF 40/1 and guanidine in four concentrations.
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